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ABSTRACT 
 
 
The present study examined the distribution of six genetic variants (CYP17A1, 
CYP3A4, SRD5A2, KLK3, AR) in the androgen biosynthesis and metabolism 
pathway, in 14 sub-Saharan African populations. These polymorphisms have been 
implicated in several complex diseases, most notably prostate cancer.  In order to 
elucidate the frequencies of these genetic variants, PCR-RFLP and STR based 
methodologies were employed. Consistent with previously reported results, the 
frequency distribution of the gene variants in the examined populations greatly 
coincided with prostate cancer incidence and geographic origin. Populations of 
African descent had the highest frequencies of the alleles that are postulated to 
increase risk to prostate cancer, whilst Asian populations had the lowest. Also, 
there were evident differences in the frequencies of these variants between 
populations of different continental origin particularly between African and Eurasian 
populations. The distribution of these genetic variants was further used to assess 
the spectrum of variation within Africa. The results were greatly aligned with those 
previously reported, providing further support to the origin and evolution of modern 
humans from Africa as well as other historic events. 
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1 INTRODUCTION 
 
1.1. HUMAN GENOMIC VARIATION 
 
The distribution of genetic variation within and amongst populations has proven to be 
an invaluable tool in determining the genetic structures of populations and in the 
inference of human evolutionary history (Zhivotovsky et al. 2003). Not only does 
analysis of human genetic variation elucidate the origins and evolution of modern 
humans, but it also plays a crucial part in determining which subset of variation is 
responsible for disease susceptibility (Jorde et al. 2001). 
 
1.1.1 History of genetic variation 
 
The curiosity of humans to know their origins (Jobling and Tyler-Smith 1995) and to 
understand the conspicuous differences amongst themselves dates back to 
antiquity (Carvalli-Sforza et al. 1994). The attempts to address these questions 
have been subject to scientific scrutiny for several centuries.  
 
Gregor Mendel, the father of genetics, who whilst experimenting with garden peas, 
discovered the principles of heredity and founded the rapidly expanding discipline 
of genetics, provided the first window of insight into these differences (Tan and 
Brown 2006). However, the first studies to show clear-cut genetic variation at a 
molecular level were performed by Landsteiner in 1901, using ABO blood groups 
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(Cavalli-Sforza et al. 1994).  For decades after the initial demonstration of genetic 
variation using ABO blood groups, protein polymorphisms, also known as classical 
polymorphism, were routinely used to study genetic variation as they were 
abundantly expressed in the nucleus. However, analysis using protein 
polymorphisms was limited due to their homogenous distribution across world 
populations (Harding and McVean 2004).  The full extent of genetic variation 
amongst populations was only realized when analysis was carried out at a DNA 
level (Cavalli-Sforza et al. 1994).   
 
Analysis at the DNA level not only led to the identification of gene variants that 
causes monogenic disorders but it also shattered the preconceived notion that 
most variation was between continental groups. Only 10% of all genetic variation 
could be attributed to differences between continental groups despite the clearly 
evident differences amongst the continental groups, whilst the bulk of genetic 
variation was found between individuals of the same population group (Romualdi et 
al. 2002). Although the differences in genetic variation between continental groups 
might seem small, it is these differences that are partially responsible for the 
differences in physical appearances as well as disease susceptibility (Bamshad et 
al. 2003).  
 
With advances in DNA typing, sequencing technologies and the successful 
completion of the Human Genome Project (HGP) a plethora of information on 
genetic variation came to surface (Jorde et al. 1998). This information on genetic 
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variation is increasingly being used to understand the genetic influences in 
complex diseases with the intention of developing strategies for prevention, 
diagnosis and drug development (Cardon et al. 2003).  
 
1.1.2 Analysis of genetic variation 
 
In order to determine the extent of genetic variation amongst individuals, some form 
of analysis needs to be performed. Several evolutionary forces are responsible for 
the patterns of genetic variation that are seen within and between populations.  All 
genetic variation is introduced into populations through mutations, whilst genetic 
processes like drift, selection, recombination (Cavalli-Sforza et al. 1994) coupled with 
demographic and historical processes contribute to either the maintenance or the 
reduction of genetic variation (Jorde et al. 1998).  
 
Mutations occur randomly in the human genome at different gene loci. It is these 
mutations, also called genetic markers, which are used to assess the level of 
genetic variation amongst different individuals. These can consist of single 
nucleotide polymorphisms (SNPs), short tandem repeats (STRs) and insertions 
(Cavalli-Sforza and Feldman 2003). In the current study two types of genetic 
markers, SNPs and STRs, have been employed to assess genetic variation in sub-
Saharan African populations. 
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Analysis of genetic variation using SNPs and STRs in different genetic systems 
such as autosomal DNA, mitochondrial DNA (mtDNA) and the non recombining 
portion of the Y chromosome (NRY), have been successfully exploited in order to 
study the full extent of human genomic variation (Ray et al. 2004) and to also 
discern the origins of man.  Also more recently, there has been an increase in 
investigations trying to elucidate which subset of these variants is responsible for 
disease phenotypes (Cardon et al. 2003). SNPs and STRs both have attributes 
that make them attractive for studies on both evolution and disease susceptibility. 
 
SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) 
 
SNPs are single base pair differences between individuals in the same position in a 
DNA sequence. SNPs are the simplest and commonest type of markers (Gray et al. 
2000). It is estimated that there are at least 10 million SNPs in the human genome 
(Keita et al. 2004). Of these, it is predicted that only 50 000- 250 000 have a small to 
moderate effect on disease manifestation (Rebbeck et al. 2004). 
 
SNPs are sometimes referred to as unique event polymorphisms as they tend to 
reflect unique evolutionary events. Thus individuals with the same variant allele are 
most likely to share the same evolutionary history (Stoneking 2001) although the 
possibility of independent evolution cannot be eliminated. SNPs undergo a relatively 
slow rate of change, making them quite stable and thus very constructive when 
examining the effects of long-term population subdivision (Romualdi et al. 2002). 
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Also, studying the distribution and allele frequencies of SNPs in different populations 
has contributed in the understanding of human origins (Taylor et al. 2001) and the 
age of specific mutations (Erichsen and Chanock 2004). 
 
In the post genomic era, interest in SNPs has reached burgeoning proportions. This 
interest is in direct correlation with the quest to find genetic variants that predispose 
to complex diseases (Miller et al. 2001) and lead to adverse drug effects (Lin and 
Wu 2005). 
    
SHORT TANDEM REPEATS (STRs) 
 
STRs are simple sequence repeats (Shastry 2002), which are broadly and evenly 
distributed throughout the genome. They exhibit high levels of allelic variation (Gray 
et al. 2000) due to their high mutation rate (Zhivotovsky et al. 2003). This attribute 
has made them invaluable when trying to determine patterns of recent divergence 
(Romualdi et al. 2002), elucidate the evolutionary relationships of human populations 
(King et al. 2000) as well as make inferences on population expansions and 
migrations (Zhivotovsky et al. 2003). The increased utilization of STRs in genetic 
variation studies has shown the higher levels of diversity that is present in African 
populations (Harpending and Cochran 2006).  
 
They have also been exploited in gene mapping efforts for Mendelian diseases using 
linkage analysis with huge success. Although most STRs are considered neutral, 
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some have been reported to manifest in a disease phenotype when highly expanded 
(King et al. 2000).  
 
1.2. GENETIC VARIATION IN SUB-SAHARAN AFRICA 
 
Sub-Saharan Africa is not only a region that has important historical implication for 
all modern humans but it is also the region where the most genetic diversity is 
observed. However, despite all these virtues, it still remains largely understudied 
(Tishkoff and Williams 2002).   
 
Following comprehensive research on the origins of mankind, the “Out of Africa” 
theory has become a widely accepted hypothesis. Several genetic findings have 
strengthened the validity of this theory (Jorde et al. 2001). The “Out of Africa” theory 
states that Homo sapiens initially evolved in Africa and that a group of about 1000 
individuals left East Africa approximately 100 000 years ago to colonize the rest of 
the world. Archaeological and genetic evidence are in concordance in the view of a 
recent exodus of humans from Africa to colonize the rest of the world (Cavalli-Sforza 
and Feldman. 2003). It is thus of primary importance to study variation patterns in 
African populations as present day African populations harbour in their genomes 
information that is crucial in understanding the evolutionary processes of our species 
and the mechanisms that have produced the complex patterns of genomic variation 
found in all humans.   
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1.2.1 Complex diseases and Africa 
 
There has been a noticeable increase in the prevalence of complex diseases in 
developed nations in the past two decades (Altmϋller et al. 2001). Although the 
aetiology of complex diseases like prostate cancer is still a conundrum (Wright et 
al. 1999), the familial tendency of most complex diseases strongly suggests a 
genetic contribution to these diseases (Gray et al. 2002). This has prompted 
extensive investigations to understand the genetic basis of complex diseases.  
 
Complex diseases result from the adverse interactions between multiple genetic 
variants of varying penetrance and environmental factors. However these two 
factors do not act solely to bring about the disease state (Wright et al. 1999).  
Association studies have been widely used to determine which gene variants 
predispose to complex diseases at a population level (Cardon et al. 2003) as 
linkage analysis, which had successfully mapped almost all Mendelian disease 
genes (Pritchard and Cox 2002), has lacked the ability to detect gene variants that 
have a small and modest effect on complex disease susceptibility.  
 
The principle behind association studies is to link differences in incidence rate with 
differences in allele frequencies between groups. However differences in allele 
frequency between groups doesn‟t necessarily mean that the variant is associated 
with the disease phenotype, as demographic and historical processes are also 
responsible for differences in allele frequencies (Cardon et al. 2003). This is why it is 
imperative to understand the evolutionary processes that have shaped the genetic 
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variation in the ancestral African population as well as the populations it gave rise to, 
as it will aid in distinguishing disease-causing genetic variation from stochastic 
genetic variation that is shaped by historical and demographical processes (Reich 
and Lander 2001). 
 
Individuals of African descent often have a high prevalence of complex diseases 
(Tishkoff and Williams 2002). Studies conducted in Jamaica and Brazil have shown 
that individuals of sub-Saharan African descent have a higher risk of developing 
prostate cancer than individuals of either European or Asian descent (Reddy et al. 
2003). Therefore, in order to answer questions on the high prevalence of complex 
diseases in individuals of African descent as in the case of African Americans, 
studies among present day African populations would shed more light on the 
evolution of the gene variants associated with disease. Furthermore most of the 
environmental factors, which trigger disease manifestation are not highly prevalent 
in African populations, this will consequently allow for the discrimination of genetic 
influences from the environmental influences (Tishkoff and Williams 2002).  
 
1.3. PROSTATE CANCER 
 
Prostate cancer is one of the complex diseases that differ with prevalence among 
ethnic groups (Hsing et al. 2000).  African-Americans have the highest reported 
incidence of prostate cancer, which is 60% greater than their European-American 
counterparts (Keita et al. 2004) and 30-50 times higher than the low risk Asian 
group (Hsing et al. 2001).  
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Prostatic cell growth is maintained and regulated by circulating androgens 
(Makridakis and Reichardt 2001). The importance of circulating androgens in 
prostate cells was highlighted, when the administration of testosterone to lab rats 
induced prostatic cell growth. Following on this observation, researchers examined 
the genes involved in the androgen biosynthesis and metabolism pathway as 
candidates for prostate cancer susceptibility. The interest in these gene markers 
was further elevated, when these variants were found to be differently distributed 
among the different populations (Habuchi et al. 2000). Moreover, the distribution 
pattern of these variants was highly similar to prostate cancer incidence (Kittles et 
al. 2002; Hsing et al. 2001). Currently there is paucity of data on the allele 
frequencies and distribution of these gene variants in African populations. Thus a 
robust examination of the candidate gene markers among sub-Saharan African 
populations would shed light in their distribution in Africa and guide future prostate 
cancer studies.  
 
The current study focuses on six genetic markers (Five SNPs and one STR) that 
have been discovered in the androgen biosynthesis and metabolism cascade. 
These include the cytochrome P450c17α (CYP17A1, -34T>C), cytochrome P450 
3A4 (CYP3A4, -392A>G), Steroid 5α reductase type II (SRD5A2, V89L and A49T), 
Androgen Receptor (AR, CAGn) and the Kallikrein Related Peptidase 3 gene 
(KLK3, -158A>G) gene variants. A diagrammatic presentation of where the 
different variants play a role in the cascade is shown in figure 1.1.    
    10 
 
Figure 1.1. The androgen metabolism and biosynthesis cascade. The genes examined in the current study are highlighted in 
green text boxes. Steroid abbreviations: Preg, pregnenolone; DHEA, dehydroepiandrosterone; T, testosterone; DHT, 
dihydrotestosterone (Adapted from Makridakis and Reichardt 2001) 
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1.3.1. The cytochrome P450c17α (CYP17A1)  
 
The CYP17A1 gene maps to chromosome 10q24.3 and is made up of eight exons 
(Gsur et al. 2000). This gene encodes the cytochrome P450c17α enzyme which 
catalyses the activity of both the 17α-hydroxylase and the 17,20-lyase (Allen et al. 
2001). These two enzymes play critical roles in two sequential rate-limiting steps in 
the biosynthesis of testosterone. Initially cholesterol enters the mitochondria and is 
converted to pregnenolene by CYP11A1 (Kittles et al. 2001). Pregnenolene is then 
converted to 17αhydroxypregnenolene by 17 α-hydroxylase and finally to 
dehydroepiandrosterone (DHEA) by the enzyme 17,20-lyase. DHEA, the precursor 
of testosterone, is the first intermediate product in the testosterone biosynthetic 
pathway, which shows some level of androgenic activity (Gsur et al. 2000). The 
conversion of pregnenolene to DHEA takes place in the mitochondria and 
endoplasmic reticulum of the testis and the adrenal cortex. 
 
A -34T>C substitution has been identified in the promoter region, 34 bases from 
the initiation site of translation and downstream from transcription start site (Sharp 
et al. 2004). This substitution leads to an additional Sp1-type (CCACC) promoter 
site.  Since the number of promoter sites is directly correlated with the transcription 
activity of a gene, this substitution was hypothesized to lead to an increased risk to 
prostate cancer due to the increase in transcription activity of the CYP17A1 gene 
and as a consequence increased the amount of available testosterone. It was 
however later shown that the variant allele did not appear to influence Sp-1 binding 
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(Ntais et al. 2003). Furthermore the variant allele did not increase levels of 
circulating testosterone (Allen et al. 2001). 
 
Several case control studies have been conducted to try and determine the effect 
of the variant allele. These studies however still remain largely inconclusive. Whilst 
some have found a positive association of the variant C allele with risk for prostate 
cancer (Gsur et al. 2000; Lunn et al. 1999; Kittles et al. 2001), others found the 
more commonly distributed T allele to increase its risk (Habuchi et al. 2000). In a 
meta-analysis that was performed, it was found that the variant allele might have 
important implications for prostate cancer susceptibility in individuals of African 
descent, but more extensive research on African individuals needed to be 
performed in order to form conclusive results (Ntais et al. 2003).   
 
The variant allele was found to be distributed with varying frequencies across the 
different world populations. Individuals of East Asian origin exhibit the highest 
frequency of homozygosity for the variant allele whilst African individuals had the 
lowest (Sharp et al. 2004).  
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1.3.2. The cytochrome P450 3A4 (CYP3A4) 
 
Of the P450 cytochrome supergene family, the cytochrome P450 3A4 is the most 
abundantly expressed P450 enzyme in the human liver (Gsur et al. 2004).  
Members of the P450 cytochrome family are involved on the oxidation of a number 
of foreign compounds like drugs, xenobiotics and carcinogens (van Schaik et al. 
2000). The CYP3A4 gene, which maps to chromosome 7q21.1, is responsible for 
the oxidation of more than 50% of all drugs (Cavalli et al. 2001). 
 
The interest in this gene in relation to prostate cancer was sparked by its role in the 
oxidative deactivation of testosterone to the biologically less active forms, 2β, 6β- 
or 15β-hydroxytestosterone. The protein product of this gene was however found 
to be only expressed in 61% of all prostate tumors, thus signifying tumor specific 
variability in the expression of this gene. An -392A>G variant was identified in the 
5‟ regulatory region of the CYP3A4 gene. It was suggested that this variant allele 
increases the risk to prostate cancer by decreasing the transcriptional activity of 
the gene and thus lead to elevated levels of circulating testosterone (Rebbeck et 
al. 1998).  
 
Several studies have been performed to assess the functional implications of the 
variant allele with regards to prostate cancer.  Positive associations for the variant 
allele with prostate cancer have been described for both European and African 
American populations (Rebbeck et al. 1998; Paris et al. 1999) whilst another study 
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demonstrated that population stratification can confound results of case-control 
studies, especially in highly admixed populations like African Americans (Kittles et 
al. 2002).  
 
The variant allele is found to differ significantly in the different world population 
showing a pattern that is very similar to prostate cancer incidence (Kittles et al. 
2002). The variant G allele was found with a frequency of 0.8 in African 
populations, 0.6 in African-American, 0.07 in European-American and 0 in Asian 
populations (Tayeb et al. 2000; Cavacco et al. 2003; Rebbeck et al. 1998; Zeigler-
Johnson et al. 2002; Kittles et al. 2002; Paris et al. 1999; Van Schaik et al. 2000; 
Plummer et al. 2003; Cavalli et al. 2001). 
 
 
1.3.3. Steroid 5α Reductase Type II (SRD5A2) 
 
The SRD5A2 gene, located on chromosome 2p23, covers a region of 
approximately 40kb and consists of 5 exons and 4 introns (Hsing et al. 2001). 
Although two isozymes of the gene exist, the SRD5A1 and SRD5A2, the latter is 
solely expressed in prostate cells (Febbo et al. 1999). 
 
The SRD5A2 enzyme is responsible for the irreversible conversion of testosterone 
to its more potent form, dihydrotestosterone (DHT). DHT has a binding affinity that 
is 5 times higher than testosterone (Ntais et al. 2003). DHT subsequently binds to 
the androgen receptor (AR) and this DHT/AR complex transactivates a number of 
genes in order to bring about cellular proliferation in the prostate (Hsing et al. 
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2001). Deficiency of SRD5A2 enzyme in males leads to a highly underdeveloped 
prostate (Makridakis and Reichard 2001), and also leads to presentation of 
pseudohermaphroditism at birth (Vilchis et al. 1997), thus stressing the importance 
of a normally functioning SRD5A2 in prostate cells. 
 
It was then suggested that variation in the SRD5A2 gene could explain the 
differences in incidence of prostate cancer among the different ethnic groups.  
Several data supported this hypothesis (Hsing et al. 2001). Firstly, when assessing 
the activity of the enzyme using its known metabolites, African-Americans had the 
highest activity, followed by European-Americans and lastly by the low risk 
Japanese group (Ross et al. 1992). Secondly, the DHT:testosterone ratio was 
lowest in Asians and highest among African-Americans men (Ntais et al. 2003). 
This led to the quest to find markers in the SRD5A2 gene that might be responsible 
for these discrepancies. Two missense mutations were subsequently identified in 
the first exon of the SRD5A2 gene (See figure 1.4), the V89L and the A49T (Gsur 
et al. 2004). 
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Figure 1.2 A diagrammatic presentation of exon 1 of the SRD5A2 gene with the 
A49T and V89L polymorphisms (Adapted from Makridakis et al. 2001) 
 
THE V89L POLYMORPHISM 
 
The V89L polymorphism is caused by a G to C transversion in codon 89, which 
changes the amino acid valine to leucine. The C allele was shown to decrease 
enzyme activity by 30% (Coughlin et al. 2002) and was thus assumed to confer 
protection to those who harboured it due to the decreased DHT production (Ribeiro 
et al. 2002).  The distribution of the C allele was also highly correlated with the 
incidence of prostate cancer, lowest in African-American males and highest in men 
of Asian origin (Hsing et al. 2001). This variation prompted the performance of 
various studies to determine if the G allele was associated with risk to prostate 
cancer. Despite all the studies executed, association of the G allele with prostate 
cancer risk still remains inconsistent.  Some studies found a positive association 
for the G allele with risk and progression to prostate cancer (Nam et al. 2001 and 
Hsing et al. 2001), others found the C allele to increase risk to prostate cancer 
(Söderström et al. 2002, Giwercman et al. 2005 and Salam et al. 2005), whilst 
EXON 1 
A49T V89L 
EXON 2 
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others found no association (Lunn et al. 1999; Jaffe et al. 2000; Febbo et al. 1999; 
Nam et al. 2003; Pearce et al. 2002).   
 
THE A49T POLYMORPHISM 
 
The A49T polymorphism is the replacement of an alanine amino acid by a 
threonine at codon 49. The variant allele exhibited enzyme activity that was 5 fold 
higher in vitro than the normal allele. Since the variant allele increases the activity 
of the enzyme, and consequently the production of DHT, it was postulated to 
increase risk to prostate cancer through increased DHT production (Gsur et al. 
2004). 
 
Contradictory results on the association of the variant allele with risk to prostate 
cancer have been observed. Some studies have noted a significant increase in risk 
to prostate cancer if individuals carry the variant allele (Makridakis et al. 1999; 
Jaffe et al. 2000), whilst some have found no association (Hsing et al. 2001; 
Söderstrom et al. 2002; Shibata et al. 2002). In a meta-analysis that was 
performed, it was postulated that the variant allele might have a modest effect on 
risk to prostate cancer but further studies were required to exclude the possibility of 
a bias or chance findings (Ntais et al. 2003). 
 
The variant allele is found in very low frequencies across the different populations, 
ranging from frequencies of 0.01 in Africans and African-Americans to 0.25 in 
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populations of European origin. The variant allele has so far not been found in 
Asian populations (Allen et al. 2003; Söderstrom et al. 2002; Hsing et al. 2001; 
Makridakis et al. 1999; Zeigler-Johnson et al. 2002; Ribeiro et al. 2002). 
 
1.3.4. The Kallikrein Related Peptidase 3 gene (KLK3)  
One of the critical roles of the AR is to activate the transcription of certain genes in 
order to bring about cell proliferation in the prostate. It performs this task by binding 
to specific nucleotide sequences known as androgen response elements (AREs), 
which are found in the promoter region of the candidate genes. One such gene is 
the KLK3 gene, also known as the Prostate Specific Antigen.  
 
The KLK3 gene, which maps to chromosome 19q23, was reported to have a 
polymorphic site (-158A>G) in one of its AREs. This polymorphism is hypothesized 
to cause alterations in the binding affinity of the AR with the KLK3 gene and 
consequently leads to differences in KLK3 expression (Gsur et al. 2004). 
Inconsistent results on the effect of the polymorphism on prostate cancer 
susceptibility have been noted. Some investigations yielded positive associations 
(Xue et al. 2000; Gsur et al. 2002) and even showed that interaction of the KLK3 
GG genotype with short CAG repeats (<20) increases risk to prostate cancer by 
five fold (Xue et al. 2000) whilst another study found no significant association of 
the polymorphism with prostate cancer risk (Sieh et al. 2006).  
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Paradoxical results on whether the polymorphism influences KLK3 serum 
concentrations were obtained. The AA genotype was shown to increase the KLK3 
serum levels (Xue et al. 2001) but a later study refuted such claims when it found a 
statistically insignificant lower serum levels with the AA genotype (Xu et al. 2002). 
  
The KLK3 gene also encodes a glycoprotein that is secreted by the prostatic 
epithelial cells (Xu et al. 2002). Since it discovery in 1979, the prostate specific 
antigen (PSA) serum measurements has been routinely used for the early 
detection and in monitoring the progression of prostate cancer (Gsur et al. 2004), 
as anything that alters the size of the prostate increases PSA serum 
measurements. PSA serum measurements also differ according to ethnicities; 
African Americans have higher measurements compared to the Caucasians (Xue 
et al. 2001).  
1.3.5. The Androgen Receptor gene (AR) 
 
The AR gene, located on chromosome Xq11-12, occupies a region of 
approximately 90kb (Kittles et al. 2001). It has three domains spanned across eight 
exons and encodes 918 amino acids. The three domains include the DNA binding, 
the androgen binding and amino terminal (N-H²) domains (Hsing et al. 2000).  
 
The AR gene is principally activated by DHT to form a complex that is able to 
activate the transcription of androgen responsive genes in order to bring about cell 
division in the prostate (Shibata et al. 2002). The amino terminal, coded by exon 
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one, is the domain that is responsible for the transactivation of these genes (Chen 
et al. 2002). It also contains a polymorphic trinucleotide (CAG) repeat unit that 
encodes a polyglutamine tract (Beilin et al. 2001).  Normal individuals usually carry 
repeat units ranging from eight to 31 (Giovannucci et al. 1997).  Highly expandable 
repeat units have been shown to have decreased transcriptional activities (Hsing et 
al. 2000). In vitro studies have shown that the removal of CAG repeats leads to an 
increase in transcriptional activity of the AR gene, thus suggesting that the CAG 
repeats play a part in inhibiting transcription of the AR gene (Chamberlain et al. 
1994). Men with exceptionally long repeats (>40), suffer from a neuromuscular 
disorder called the spinal and bulbar muscular atrophy (Kennedy„s syndrome) 
which is also characterized by testicular atrophy, androgen insensitivity and 
infertility to name but a few (Chen et al. 2002). Highly expandable alleles in other 
genes also lead to other well known genetic disorders like Huntington disease and 
spinal ataxia 1 (Chamberlain et al. 1994). 
 
Since, shorter alleles lead to increased transcriptional activity of the AR gene, and 
consequently the transactivation of genes that bring about cell division in the 
prostate, it was assumed that the short allele increase risk to prostate cancer. It 
was even suggested that with each additional CAG repeat, there was a 3 percent 
reduction in prostate cancer risk (Lange et al. 2000). Also the shorter allele were 
more prevalent in the high risk African-Americans, intermediate in the Caucasian 
populations and lowest among the low risk Asian populations (Hsing et al. 2000), a 
pattern clearly indicative of prostate cancer incidence (Xue et al. 2000). This 
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observation launched a series of investigations to determine the association 
between repeat length and prostate cancer risk. Like most association studies the 
results from such studies proved to be contradictory. Whilst some studies found a 
positive association between the short alleles with the risk (Irvine et al. 1995; Hsing 
et al. 2000; Giovannucci et al. 1997; Chen et al. 2002), earlier onset (Beilin et al. 
2001) and advancement of the prostate cancer (Sieh et al. 2006), others found no 
increased predisposition (Lange et al. 2000; Gsur et al. 2002), gleason grade 
(Shibata et al. 2002) or earlier onset to prostate cancer (Edwards et al. 2002). 
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1.4. AIMS 
 
Differences in the distribution of gene variants among the different populations 
show that some underlying genetic structure might be present among the different 
populations. Whilst the current study is not a cancer genetics study, it is however a 
population based assessment of the frequency and distribution of the gene 
variants, which are hypothesised to increase risk to prostate cancer, among 
different world populations. This study is therefore a preliminary screen of genetic 
variation at these loci among sub-Saharan African populations and makes use of 
these data for comparative analyses with populations outside of Africa. 
 
More, specifically this current project aims to address two key issues. 
 
 To determine the allele frequency distribution of six gene markers 
(CYP17A1, CYP3A4, SRD5A2 (V89L and A49T), AR and KLK3) in the 
androgen biosynthesis and metabolism pathway in sub- Saharan African 
populations. These variants have been implicated in various diseases, most 
notably prostate cancer. Thus far the frequency and distribution of these 
gene variants have been poorly investigated in African populations. This 
study aim to address this sampling bias with the intention of adding to the 
growing body of knowledge on the distribution of these variants across world 
populations. 
 To use these markers to map the spectrum of variation within Africa and to 
examine the genetic structure of some sub-Saharan African populations.  
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2 MATERIALS AND METHODS 
 
2.1 SUBJECTS 
 
In order to achieve the objectives outlined in section 1.4, DNA samples from 815 
healthy and unrelated males from 14 ethnic groups in sub-Saharan African 
populations were screened for the six polymorphisms (CYP17A1, -34T>C; 
CYP3A4, -392A>G; SRD5A2, V89L and A49T; KLK3, -158A>G and AR, (CAG)n). 
The populations studied included the southeastern Bantu speakers from South 
Africa, southwestern Bantu speakers from Namibia, Ugandans from Uganda, 
Congolese from Democratic Republic of Congo, Zambians from Zambia, Ubangian 
speakers from Central African Republic, South African Indians, South African 
Coloureds, South African Whites, Nama from Namibia, !Kung from Botswana, 
Sekele from Angola, Kwengo from Angola and the Pygmies from Central African 
Republic. Table 2.1 gives a detailed description of the different ethnic groups 
examined with the corresponding sample sizes.  
 
The DNA was extracted from the blood samples of the 815 individuals from the 
different populations. These blood samples were previously collected by Prof H. 
Soodyall and Prof T. Jenkins with the individuals‟ informed consent. The collection 
of samples was approved by the Ethics Committee from the University of 
Witwatersrand (Protocol number M050823) for research on human subjects for the 
use of these samples in the current study.  
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Table 2.1 The breakdown of the examined populations according to continental 
descent with the corresponding code, sample sizes, groupings and sampling region. 
Name  Code Grouping Sample 
size (N) 
Sampling region 
AFRICAN DESCENT 
Southeastern Bantu-
speakers  
SEB Bantu-speakers 91 South Africa 
Southwestern Bantu-
speakers  
SWB Bantu-speakers  90 Namibia 
Zambians  ZAM Bantu-speakers 55 Zambia 
Congolese  DRC Bantu-speakers 117 Democratic Republic 
of Congo  
Ugandans  UGA Bantu-speakers 120 Uganda 
Ubangian-speakers  CAR Bantu-speakers  32 Central African 
Republic  
Khoisan-speaking 
populations 
KHO Hunter and gatherer 133  
      -Nama NAMA Hunter and gatherer 19 Namibia 
      -!Kung KUNG Hunter and gatherer 27 Botswana 
      -Sekele SEK Hunter and gatherer 56 Angola 
      -Kwengo  KWE Hunter and gatherer 31 Angola 
Pygmies PYG Hunter and gatherer 27 Central African 
Republic 
South African 
“Coloureds”  
SAC Mixed ancestry 56 South Africa 
EUROPEAN DESCENT 
South African Whites  SAW European 49 South Africa 
ASIAN DESCENT 
South African Indians  SAI Asian 45 South Africa 
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Figure 2.1 A map of Africa with the different sampling regions of the examined 
populations being highlighted in grey. 
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2.1.1 COMPARATIVE DATA 
 
The data that was used for comparative purposes was obtained from various 
scientific publications. Table 2.2 gives a detailed description of the comparative 
data with corresponding codes, markers typed and the relevant references.  
 
Table 2.2 A detailed description of the populations and the screened markers that 
were used as comparative data 
NAME CODE MARKERS  REFERENCE 
African descent 
African- 
Americans AFR-AMER 
CYP17A1, 
CYP3A4, 
V89L, A49T, 
KLK3, AR 
Stanford et al. 2002; Lunn et al. 1999, Kittles 
et al. 2001, Plummer et al. 2003, Paris et al. 
1999, Zeigler-Johnson et al. 2002, Kittles et al. 
2002, Pearce et al. 2002, Makridakis et al. 
1999, Xue et al. 2000 and Xue et al. 2001  
Ghanaians GHA 
CYP3A4, 
V89L, A49T 
Tayeb et al. 2000 and Zeigler-Johnson et 
al.2002 
Nigerians NIG 
CYP17A1, 
CYP3A4, AR Kittles et al. 2001 and Kittles et al. 2002 
Senegal SEN 
CYP3A4, 
V89L, A49T Zeigler-Johnson et al. 2002 
Sierra Leone SIL AR Kittles et al. 2001 
European descent 
Austrians AST CYP17A1 Gsur et al. 2000 
Britain BRIT 
CYP17A1, 
V89L, A49T 
Allen et al. 2001 
Dutch DUTCH CYP3A4 Van schaik et al 2000 
European- 
Americans EUR-AMER 
CYP17A1, 
CYP3A4, 
V89L, A49T, 
KLK3, AR 
Stanford et al. 2002, Lunn et al. 1999, Kittles 
et al. 2001, Haiman et al. 2001, Chang et al. 
2001, Rebbeck et al. 1998, Zeigler-Johnson et 
al. 2002, Kittles et al. 2002, Plummer et al. 
2003, Paris et al. 1999, Febbo et al. 1999, 
Pearce et al. 2002, Lunn et al. 1999, Nam et 
al. 2001, Xue et al. 2000, Xu et al. 2002, Xue 
et al. 2001, Gsur et al. 2002,  
Portugese POR CYP3A4 Cavacco et al. 2003 
Scottish 
Caucasians SCOT CYP3A4 Tayeb et al. 2000 
Sweden SWE 
CYP17A1, 
V89L, A49T 
Wadelius et al. 1999, Söderstrom et al. 2002, 
Giwercman et al. 2005* 
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Asian descent 
Amerindians AMI AR Kittles et al. 2001 
Asians  ASI 
CYP3A4, 
KLK3, AR 
Paris et al. 1999, Xue et al. 2000, Kittles et al. 
2001 
Chinese CHI V89L, AR Hsing et al. 2001, Hsing et al. 2000 
Japanese JAP 
CYP17A1, 
V89L, KLK3 
Habuchi et al. 2000, Yamada et al. 2001, Okugi 
et al. 2002 
Saudi Arabia SAR CYP3A4 Tayeb et al. 2000 
U.S.  Taiwanese US. TAI CYP17A1 Lunn et al. 1999 
U.S Japanese U.S. JAP V89L, KLK3 Pearce et al. 2002, Xue et al. 2001 
Latin-Americans 
Hispanics HIS 
CYP3A4, 
KLK3, V89L 
Paris et al. 1999, Xue et al. 2001, Pearce et al. 
2002 
Mexican MEX V89L Vilchis et al. 1997 
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2.2 METHODS  
 
2.2.1 QUANTIFICATION OF DNA 
 
The DNA was extracted from the blood samples using the salting out method that 
had initially been described by Miller et al. 1988. The concentrations of the DNA 
samples were then determined employing a spectrophotometer (Nanodrop, 
Thermo Fisher Scientific). Following this, the samples were diluted with TE Buffer 
to the final concentration of 100ng/µl. 
 
2.2.2 PCR-RFLP 
 
All the DNA samples were screened for the five SNPs (CYP17A1, T→C; CYP3A4, 
A→G; SRD5A2, V89L and A49T and KLK3, A→G) employing the Polymerase 
Chain Reaction- Restriction Fragment Length Polymorphism (PCR-RFLP) analysis. 
The specific regions containing the polymorphism of interest were amplified into 
multiple copies using PCR. The PCR products were subsequently digested with 
the appropriate restriction enzymes to screen for the presence or absence of the 
polymorphisms. 
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POLYMERASE CHAIN REACTION (PCR) 
 
One of the inventions that revolutionized the field of molecular Biology was 
undoubtedly the PCR. PCR is a simple, rapid and yet robust in vitro method of 
rapidly amplifying target DNA regions into multiple copies. Predesigned and 
specific oligonucleotide primers that flank the region of interest are used to ensure 
maximum specificity of the amplification (Strachan and Read. 1996). For the 
current study, primer pairs that had been employed in previous studies were used 
to amplify the different loci (as shown in Table 2.3).   
 
All reactions were carried out in 25µl volumes but the PCR reagents and thermal 
cycling conditions required for optimal amplification of each individual SNP varied. 
Table 2.4 gives a detailed description of differences in the PCR reagents, cycling 
conditions and product sizes for each SNP.  
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Table 2.3 PCR primers used for the amplification of regions of interest 
 
 
 
 
GENE 
 
POLYMORPHISM 
 
PRIMER SEQUENCE 
 
REFERENCE 
 
CYP17A1 
 
T-C 
F 5‟ cca ttc gca ctc tgg agt cat „3 
R 5‟ gac agg agg ctc ttg ggg ta „3 
 
Habuchi et al. 2000 
 
CYP3A4 
 
A-G 
F 5‟ gga cag cca tag aga caa ctg ca„3 
R 5‟ ctt tcc tgc cct gca cag „3 
 
Van Schaik et al. 2000 
 
SRD5A2 
 
V89L (G-C) 
F 5‟ gca gcg gcc acc ggc gag g „3 
R 5‟agc agg gca gtg cgc tgc act „3  
 
Zeigler-Johnson et al. 2002 
  
A49T (G-A) 
F 5‟ gca gcg gcc acc ggc gag g „3 
R 5‟agc agg gca gtg cgc tgc act „3 
 
Zeigler-Johnson et al. 2002 
 
KLK3 
 
G-A 
F 5‟ ttg tat gaa gaa tcg ggg atc gt „3 
R 5‟ tcc ccc agg agc cct ata aaa „3 
 
Xue et al. 2000 
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Table 2.4 The PCR reaction parameters that were followed for the amplification of each SNP 
 Roche Applied Science 
† Constitutes 500mM KCl, 100mM Tris-HCl (pH 8.3) and 25mM MgCl2 
 CYP17A1 CYP3A4 SRD5A2 (V89L) SRD5A2 (A49T) KLK3 
PCR Reagents      
†Buffer (10X) 1X 1X 1X 1X 1X 
DNTPs (2.5mM) 0.1mM 0.1mM 0.1mM 0.1mM 0.1mM 
MgCl² (25mM) 0 0 1.5mM 1.5mM 0.5mM 
Primers (10µM)  0.4mM 0.2mM 0.4mM 0.4mM 0.2mM 
DMSO (100%) 0 0 10% 10% 0 
DNA 100ng/µl 100ng/µl 100ng/µl 100ng/µl 100ng/µl 
Taq polymerase 1 unit 1 unit 1 unit 1 unit 1 unit 
Final volume 25 25 25 25 25 
Cycling conditions 94ºC– 10min 94ºC – 10min 94ºC – 10min 94ºC – 10min 94ºC – 10min 
 94 ºC - 1min 94ºC - 1min 94ºC - 1min 94ºC - 1min 94ºC - 1min 
 58 ºC - 1min    X35  58ºC - 1min     X35 58ºC - 1min     X35 58ºC - 1min     X35 59ºC - 1min     X35 
 72 ºC - 1min 72ºC - 1min 72ºC - 1min 72ºC - 1min 72ºC - 1min 
 72 ºC - 10min 72ºC - 10min 72ºC - 10min 72ºC - 10min 72ºC - 10min 
PCR product sizes 421 334 330 330 300 
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VERIFICATION OF PCR PRODUCT 
 
In order to determine the success of the PCR reactions and more importantly the 
absence of contamination, 5µl of the PCR product were mixed with 3µl of ficoll dye 
and were subsequently loaded and run on a 3% agarose gel. Ethidium Bromide 
was also added to the agarose gel mixture as it intercalates with the DNA 
fragments and forms a complex that fluoresces when exposed to Ultraviolet (UV) 
light. A molecular weight ladder was also run on the gel to ensure that the product 
visualised was of the correct fragment length. PCR products of varying length were 
observed for the different SNPs (shown in Table 2.4).  
 
RESTRICTION DIGESTION 
 
After the success of the PCR was verified, the PCR products were digested with 
different restriction enzymes. Restriction enzymes recognize specific DNA 
sequences, and each time it encounters that particular sequence it will digest the 
product to produce different fragment lengths. All the SNPs in the current study 
altered the restriction sites of specific enzymes. Thus the different banding patterns 
observed following restriction digestion were able to elucidate the different 
genotypes.  
 
The restriction digestion mixture was made up in a 10µl volume. Included in the 
mixture was one unit of enzymes, 1X buffer and distilled water to make up the rest 
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of the volume. The restriction digestion mixture was then added to 20µl of PCR 
product and incubated at various temperatures for an overnight period. Table 2.5 
gives a detailed description of the parameters that were employed to ensure a 
successful restriction digestion. 
 
Following the overnight incubation period, the digest products were run on a 3% 
agarose gel. The different banding patterns were observed for each locus (as 
shown in Table 2.5) and the different genotypes were discerned. 
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Table 2.5 RFLP conditions for the detection of the SNP variants 
‡ New England Biolabs and Roche Applied Science 
† New England Biolabs 
 The fragment was not visualized on the agarose gels due to its small size 
 CYP17A1 (T-C) CYP3A4 (A-G) SRD5A2(V89L) SRD5A2(A49T) KLK3 (A-G) 
RFLP      
Enzyme †MSPA1 ‡PST1 ‡RSA †MWO †NHE1 
No. of units per enzyme 1U 2U 1U 1U 1U 
Buffer †1X ‡1X ‡1X †1X †1X 
BSA 100ηg/µl 0 0 0 100 ηg/µl 
      
Incubation temp. 37 37 37 65 37 
      
Banding patterns TT- 421 AA- 220, 81, 33,  VV- 169, 105, 
64, 19 
AA- 90, 70, (46/47), 
(17/20/21/22) 
AA- 300 
 TC- 421, 291, 130 AG- 220, 199, 81, 
33, 21 
VL- 169, 105, 
83, 64 
AT-  107, 90,70, 
(46/47), (17/20/21/22) 
AG- 300, 150 
 CC- 291, 130 GG- 199, 81, 33, 
21 
LL- 169, 105, 83 TT- 107, 90, 70, 
(46/47), (20/21/22)  
GG- 150 
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2.2.3 SHORT TANDEM REPEATS (STR) 
 
An STR based assay was employed to analyse the trinucleotide repeat unit, 
(CAG)n, in the Androgen receptor gene.  
 
ANDROGEN RECEPTOR (CAG) REPEATS 
 
The primer pair that was used to amplify the CAG repeats was previously 
described by Kittles et al. 2001. The forward primer was tagged with a fluorescent 
label called Hex that emits a green fluorescence whilst the reverse primer was 
untagged. 
 
The reaction was carried out in a 25µl volume. The following reagents were added; 
0.4µM of both primers, 0.1µM of DNTPs, 1X Taq buffer (Roche Applied Science), 1 
unit of Taq (Roche Applied Science), 1mM of MgCl2 and double distilled water to 
make up the final volume. The Taq buffer comes standard with 500mM KCl, 
100mM Tris-HCl (pH 8.3) and 25mM MgCl2. 
 
An initial denaturing cycle of 94ºC for 10 minutes preceded 35 cycles of 94ºC for 
1minute, 64ºC for 1 minute and 72 for 1 minute. This was followed by a final 
extension cycle of 72ºC for 10 minutes. 
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1µl of PCR product, 2.2 µl of Formamide Dextran and 0.3 of Rox (Applied 
biosystems) were mixed together. The formamide Dextran was used to keep the 
DNA denatured and to also prevent it from diffusing out of the gel wells. The Rox 
was used as an internal size marker in order to allow for the sizing of the different 
fragments. 1µl of the mix was loaded and run on a 4.3% polyacrylamide vertical gel 
in an ABI 377 Prism automated DNA sequencer. The GeneScan version 3.1.2 and 
Genotyper version 2.5 software packages (PE Applied Biosystems) aided in sizing 
the fragments whilst positive controls that had been previously sequenced were 
used to authenticate the results and were included in all the runs performed in the 
automated sequencer. 
 
2.2.4 DNA SEQUENCING 
 
In order to verify that the banding patterns observed after the restriction digestion 
were the correct ones and to have positive controls for STR based assays, a few 
samples were sequenced. 
 
The samples were amplified using the previously described SNP and STR 
protocols. The PCR products were then mixed with ficoll dye and run on 2% 
Nusieve gel. Nusieve gel is the preferred gel for the excision of DNA fragments as 
it has a low melting temperature. The DNA fragments were then excised from the 
gel and purified using the Nucleospin extract column (Macherey Nagel). This 
purification kit works on the premise that nucleic acid in the presence of a 
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chaotropic salt will bind to a silica membrane. The nucleic acid can then be eluted 
in the presence of an elution buffer. Following the purification of the excised DNA 
fragments, the quality and yield of the purified DNA was visually ascertained by 
running it on a 3% agarose gel. 
 
The purified DNA was then cycle sequenced. The reaction mixture consisted of 4µl 
of Big Dye Terminator Kit (Applied Biosystems), 6µl of purified DNA, 1µl of the 
forward primer (3.3mM) and double distilled water to make up a final volume of 
20µl. The reverse primers of the CYP3A4 and AR (CAG) were used for sequencing 
as the mismatched bases and fluorescent tags in their forward primers would 
interfere with the sequencing analysis. Cycle sequencing is very similar to a normal 
PCR reaction except for the use of one primer and the inclusion of fluorescently 
labeled dideoxydinucleotides (ddNTPs). The ddNTPs lack a hydroxyl group at the 
3‟ terminal of the sugar molecule and therefore cannot form a phosphodiester bond 
with the next base. Thus the incorporation of a ddNTP into a newly synthesized 
strand leads to the termination of chain elongation. The thermal cycling conditions 
for cycle sequencing where as follows; 25 cycles of three consecutive 
temperatures of 96ºC for 30 sec, 50 ºC for 15 seconds and 60ºC for 4 minute.  
 
The products of cycle sequencing were purified using the Dyex spin column 
(Qiagen) in order to remove excess ddNTPs that will interfere with the sequencing 
analysis.  
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Subsequent to the purification of cycle sequencing products, the products were  
dried in a vacuum chamber to form a pellet. The pellet was mixed with 4µl of 
Formamide Dextran. The DNA was denatured at 100ºC for 2 minutes prior to 
loading on the sequencing machine. Iµl of denatured products were loaded on the 
sequencer and run for approximately seven hours. The sequences were analysed 
using ABI 377 prism software.  
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2.3 STATISTICAL ANALYSIS 
 
2.3.1 DATA MANAGEMENT 
 
The data was recorded and managed using a spreadsheet facilitated by the 
Microsoft Excel software. Genotypes at each locus were scored in all individuals 
and their frequencies were computed for each population using direct gene 
counting. 
 
2.3.2 DATA ANALYSIS 
 
HARDY-WEINBERG EQUILIBRIUM 
 
In order to determine if there were any deviations from Hardy-Weinberg 
Equilibrium, Arlequin version 3 was used (Excoffier et al. 2005). Hardy-Weinberg is 
the state where the genotypic frequencies observed in the population are the result 
of random mating. Several factors can lead to deviations in Hardy Weinberg; these 
include selection and genetic drift.  Individual populations were all tested at each of 
the loci for deviations from the state of Hardy Weinberg Equilibrium. 
 
INTRA-POPULATION DIVERSITY 
 
The level of intrapopulation diversity for the current study was assessed at two 
levels. Firstly, the overall extent of gene differentiation exhibited by each population 
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using all the markers was examined. This allowed for the distinction of which 
populations exhibited the most overall genetic diversity for the markers examined.  
This level of analysis was computed using the software Dispan (Dispan 1993) 
 
The extent of gene differentiation exhibited by each population for each individual 
marker was also determined.  This was achieved using the gene diversity 
(Heterozygosity) index executed by Arlequin version 3 (Excoffier et al. 2005). The 
amount of genetic diversity observed in a population and specific markers can aid 
to make inferences on the age of the polymorphism as well as the demographic 
history of a particular population. 
 
INTER-POPULATION DIFFERENTIATION 
 
In order to determine the statistical significance of the variation in allele frequencies 
between the different populations examined, two-tailed Fisher‟s exact test 
implemented by GraphPad InStat version 3.00 (for Windows XP, GraphPad 
Software, San Diego California USA, www.graphpad.com). The allele frequencies 
of various world populations were also compared to the frequencies of the currently 
examined populations in order to detect variations that were of statistical 
significance. 
 
Furthermore, the Wrights Fst Statistic was computed using Genetic Distance 
Analysis programme to quantify the extent of between-population variation, among 
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different population groupings populations (Lewis and Zaykin 2000). The Fst 
statistic provides a good measure of the amount of genetic differences between 
populations. The higher the Fst statistic, the greater the between-population 
differentiation amongst that grouping. 
 
ANALYSIS OF GENE FLOW 
 
In order to determine the extent of gene flow within the examined populations, the 
model that was described by Harpending and Ward (1982) was employed. This 
was achieved by plotting the distance from the centroid (Ri) vs. heterozygosity. 
Based on this model, there is an expected simple and linear relationship between 
these two variants. The distance from the centroid was calculated according to this 
formula, Ri = (pi –P)2/(P)(1-P), where pi is the frequency of the variant alleles in a 
population i and P is the frequency of the variant alleles in the total populations. 
This equation was used for all six individual gene variants and was then averaged 
out across all the gene variants. 
 
POPULATION AFFINITIES 
 
The allele frequency data was also to generate population pair-wise genetic 
distances (DA distances) using the Dispan programme (Dispan 1993). Using these 
population pair-wise genetic distances, neighbour joining tree was constructed in 
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order to infer the genetic affinities of the examined populations. Tree analysis 
provides for a visual form of assessing population similarities and diversities. 
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3 RESULTS 
 
3.1 SCREENING OF SAMPLES 
 
Having screened 815 male samples from 14 sub-Saharan populations for six 
genetic markers, the individual genotypes of the various markers were ascertained 
by gene counting. Allele frequencies were also determined using direct counting at 
each locus and for each population.  The genotypes of the five SNP variants were 
ascertained using PCR-RFLP whilst the Androgen Receptor repeats units were 
determined employing STR based methodologies.  
 
Figure 3.1 (a-e) shows the various banding patterns on agarose gel of the five SNP 
variants that were observed following restriction digestions to elucidate the 
respective genotypes. Figure 3.2 is an example of an individual‟s STR profile for 
the AR (CAG) repeats with the corresponding sequence data. 
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A)              B)                 C)      
 
 
 
 
 
              D)                               E)  
 
Figure 3.1 The banding patterns observed following digestion of the various SNP variants (i, Homozygous wild-type; ii, 
Heterozygous and iii, Homozygous for the mutant). A) CYP17A1; B) CYP3A4; C) SRD5A2 (V89L); D) SRD5A2 (A49T) 
and E) KLK3.  
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Figure 3.2 An STR profile of a sample with the corresponding sequence data. 
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3.2 ALLELE AND GENOTYPE FREQUENCY DISTRIBUTION 
 
3.2.1 Cytochrome P450c17α (CYP17A1) 
 
The allele frequency distribution of the C allele amongst the 14 populations as well 
as comparative data from other sources is given in Figure 3.3. Varying frequencies 
of the variant allele were noted with the highest frequencies being 0.61, 0.59, 0.59 
and 0.52 in the Nama, !Kung, Pygmies and Kwengo, respectively. The SAI and 
Ubangian speakers from CAR had the lowest observed frequencies of 0.24 and 
0.22, respectively.  
 
Following population pair-wise comparisons, a significant difference between 
the Ubangian speakers from CAR and pygmies was noted (P< 0.0001) 
despite the close living proximities of these two populations. Whilst the CAR 
had the lowest observed frequency of the variant C allele, the Pygmies had 
the second highest frequency (shown in figure 3.3). 
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Figure 3.3 Distribution of the CYP17A1 (C) across world populations 
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3.2.2 The cytochrome P450 3A4 (CYP3A4) 
 
There was a marked difference in the distribution of the G allele among populations 
from the different continents. The variant G allele was prominent in African 
populations with frequencies ranging from 0.67 to 0.85 (see Figure 3.4). Of the 
African populations, the !kung had the highest frequency (0.85) for the variant 
allele and was the only population that had no individuals that were homozygous 
for the A allele. However, frequencies of below 12% were found in the SAW and 
SAI populations from the current dataset. The SAI had the lowest frequency for the 
G allele and also did not have any individuals that were homozygous for the G 
allele, contrary to the !Kung population. Moreover the SAC were found to have 
frequencies that were intermediate between these two populations. 
 
 Consistent with patterns observed in the current dataset, data from other sources 
also showed that the African populations possess the highest frequencies of the 
variant allele. Also, the frequency distribution of the variant allele decreased 
considerably with increasing distance from Africa (shown in figure 3.4). 
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3.2.3 Steroid 5α Reductase Type II (SRD5A2) V89L 
 
The V89L polymorphism was also found to be differently distributed among the 
different populations. A trend of increasing distribution with increasing distance 
from Africa was noted. The protective leucine amino acid was found at highest 
frequencies in populations of Asian (0.4 in SAI) and European (0.37 in SAW) 
descent in our current dataset and lowest in the hunter gatherer populations with 
the exception of the Kwengo.  
 
When pair-wise population comparisons were computed, the Kwengo were found 
to differ significantly from the other two Khoisan populations, the Nama (P=0.0350) 
and the Sekele (P=0.0027). On the contrary, when the Kwengo population was 
compared to all the Bantu speaking populations, no significant differences were 
noted. 
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Figure 3.5 Distribution of the SRD5A2 (V89L) allele across world populations 
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3.2.4 Steroid 5α Reductase Type II (SRD5A2) A49T 
 
Of the six loci that were examined, the A49T gene variant was the only one to be 
found to be highly monomorphic. The low levels of variability exhibited by this 
variant have been previously documented. In our current dataset, the T variant was 
only noted in three of the populations, the Nama, SAC and SAW with frequencies 
of 0.027, 0.026 and 0.02, respectively. No individuals from our current dataset 
were found to be homozygous for the threonine allele.  
 
Four African individuals were found to be heterozygous for the variant allele (three 
SAC and one Nama). Although the threonine allele has been found in other African 
populations viz. Senegal, Ghana and African- American albeit in very low 
frequencies (0.01), this allele was not detected in the currently examined African 
populations except for the individuals in the Khoisan and SAC populations. 
Consistent with previous reports on the absence of the variant allele in Asian 
populations (Hsing et al. 2001), this allele was also not found in the SAI population. 
The threonine allele, in the presence of published data, was found in higher 
frequencies in populations of European descent. 
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Figure 3.6 Distribution of the SRD5A2 (A49T) across world populations 
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3.2.5 Kallikrein Related Peptidase 3 gene (KLK3) 
 
The KLK3 (G) allelic variant was found at varying frequencies in the examined 
populations. In contrast to the other markers, there was no distinct trend followed in 
the distribution of the allelic variant amongst the different populations that 
coincided with geographic origin.  The highest frequencies were observed in the 
Nama and SWB with frequencies of 0.66 and 0.59, respectively whilst the lowest 
were however noted in the CAR and Zambia populations with frequencies of 0.36 
and 0.35 respectively. 
 
Although the variant allele has been previously reported in frequencies as high as 
0.81 in populations of Asian descent, these high frequencies were not observed in 
the SAI populations, which was only 0.54. Also, in the presence of comparative 
data, Asian populations usually have the highest reported frequencies amongst the 
dataset, but in our current dataset, the SAI did not show this pattern, as it did not 
have the highest frequency of the variant G allele. When the SAI was compared to 
another population of Asian descent, the Japanese- Americans, a statistically 
significant difference was noted (P< 0.0001). 
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Figure 3.7 Distribution of the KLK3 (G) across world populations 
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3.2.6 Androgen Receptor (AR) 
 
Figure 3.8- 3.9 illustrates the distribution of the AR CAG repeats in the examined 
populations. The number of repeats ranged from 7-39 repeat units. The shortest 
repeat units were found in two individual, one from the DRC and another from the 
Ugandan populations. The individual with the longest repeat unit was from the 
Nama population (see figure 8).  
 
There was a great distinction in the distribution of repeat units of less than 20 
amongst the populations of African descent. Whilst the Bantu-speaking populations 
were found to have a high prevalence of the short repeat units, the same trend was 
not noted in other African populations viz. the Hunter and Gatherer populations 
(Nama, !Kung, Kwengo, Sekele and Pygmies) and SAC. Moreover, all the Bantu-
speaking populations with the exception of Uganda possess modal repeat units 
that were less than 20 (see table 3.1). The Eurasian populations (SAW and SAI), 
on the other hand, also exhibited very low frequencies of these repeat units.  
 
 In the presence of comparative data (see Table 3.1), other populations of African 
descent like Nigeria, Sierra Leone and African-Americans were also found to have 
a high frequency of repeat units of less than 20 (Kittles et al. 2001). 
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Table 3.1 The breakdown of the distribution of the AR CAG repeat units in the 
examined populations.  
Population N No. of alleles Range Modal repeat unit 
AFRICAN  
SEB 91 14 13-26  17 
SWB 90 13 14-30 18 
ZAM 55 14 12-27 17 
DRC 117 17 7-28 18 
UGA 120 16 7-30 21 
CAR 32 12 14-26 16, 17, 18 
PYG 27 10 12-26 22 
NAMA 19 12 14-39 21 
!KUNG 27 10 14-26 23 
SEK 56 13 13-29 20 
KWE 31 8 17-25 21,22,23,25 
*SIL 230 17 10-26 16 
*NIG 83 18 5-28 16 
MIXED ANCESTRY     
SAC 56 14 7-32 20 
*AFR-AMER 516 21 9-31 15 
EUROPEAN     
SAW 49 10 18-28 23 
*EUR-AMER 87 11 13-26 20 
ASIAN     
SAI 45 13 17-30 24, 26 
*ASI 60 12 14-26 20 
*AMI 80 14 14-30 22 
* Comparative data from Kittles et al. 2001 
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Figure 3.8 Allelic distribution of the CAG repeats in the present study (see Table 2.1). 
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Figure 3.9 The distribution of  AR alleles (<20 and >20 repeats) in the populations examined in the current study as well 
as comparative data (see Table 2.1) 
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3.3 POPULATION STATISTICS 
  
 
3.3.1 Hardy Weinberg Equilibrium (HWE) 
 
All the populations were tested to determine whether they deviated from the HWE 
for any of the loci tested. The CYP17A1 and the A49T loci were the only loci found 
to be in Hardy Weinberg Equilibrium for all the populations.  
Seven out of the 70 tests performed for Hardy Weinberg Equilibrium showed 
significant departure from the Equilibrium state (Table 3.2). The SAW was the only 
population that deviated from the equilibrium state for the CYP3A4 locus showing a 
statistically significant P value of 0.00756. For the V89L locus, three Bantu-
speaking populations, SEB, DRC and Uganda showed a statistically significant 
departure from Hardy Weinberg Equilibrium with P values of 0.00602, 0.00014 and 
0.00213 respectively. Due to the fact that the A49T was highly monomorphic in 
most of the examined populations, the test could not be performed in those 
populations. Significant deviations from HWE were noted for the KLK3 locus in 
three African populations, SEB (P=0.03591), Nama (P=0.00592) and CAR 
(P=0.00491). However, since these departures were not restricted to specific 
populations or loci, they are probably the result of random statistical fluctuations. 
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Table 3.2 Hardy Weinberg Equilibrium proportions for the examined populations.  
(Deviations from Hardy Weinberg Equilibrium are highlighted in bold)  
 
 
  P-values at 95% confidence interval 
Populations N CYP17A1 CYP3A4 V89L A49T KLK3 
African       
SEB 91 0.22638   0.31516   0.00599   - 0.03591   
SWB 90 0.80058   0.56339   1.00000   - 0.82727   
ZAM 55 1.00000   0.26192   0.76233   - 0.37786   
DRC 117 0.53529   1.00000   0.00002   - 0.26235   
UGA 120 0.14922   0.83440   0.00118   - 0.36585   
CAR 32 1.00000   0.42754   0.68363   - 0.00491   
PYG 27 0.69559   0.36572   0.07371   - 0.43219   
NAMA 19 0.63185   0.60713   1.00000   1.00000   0.00592   
!KUNG 27 0.42617   1.00000   0.11987   - 1.00000   
SEK 56 0.78651   0.30178   1.00000   - 0.06403   
KWE 31 0.48507   0.64409   0.63796   - 0.07259   
SAC 56 0.77798   0.17483   0.74998   1.00000   0.40853   
European       
SAW 49 0.75331   0.00733   1.00000   1.00000   0.12633   
Asian       
SAI 45 0.09167   1.00000   0.06904   - 0.55532   
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3.3.2 INTRAPOPULATION DIVERSITY 
 
The overall gene diversity for all the population was determined (shown in Table 
3.3). The African populations had the highest overall diversity amongst the three 
continental groups, followed by the European and Asian populations with diversity 
indices of 0.3525, 0.3235 and 0.297278, respectively. Within the African group, the 
SAC had the highest overall gene diversity of 0.387291. The lowest diversity in 
Africa was however found in the Nama, Pygmies, Kung and Sekele (see Table 
3.3). 
Table 3.3. Gene diversity for the continental groups and each of the 14 populations 
Population Genetic diversity 
AFRICAN 0.352538 
SAC  0.387291 
UGA  0.363975 
KWE 0.355473 
ZAM 0.347423 
SEB 0.349827 
CAR  0.337401 
DRC 0.334089 
SWB 0.334500 
NAM  0.315505 
PYG  0.334451 
KUN 0.307757 
SEK  0.307272 
EUROPEAN 0.323501 
SAW 0.323501 
ASIAN 0.297278 
SAI  0.297278 
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To ascertain whether African populations exhibited this high overall diversity 
across all the markers examined, the gene diversity per marker for each population 
(see Table 3.4) and per continental origin (see Figure 3.10) were determined. The 
highest diversity indices were found for the Androgen Receptor (CAG) repeats. 
However, when analysis was restricted to the SNP variants, the KLK3 gene variant 
exhibited the highest overall diversity whilst the A49T had the lowest (see Table 
3.4).  
  
For the KLK3 locus, all the populations exhibited similar diversity indices, ranging 
from 0.4619 – 0.5016 (see Table 3.4), thus showing very little differentiation 
amongst the different populations. Even when the diversity was measured 
according to continental origin, very little variation between the continental groups 
was observed (see figure 3.10). Whilst the KLK3 had the highest diversity indices, 
the A49T locus exhibited diversity values of 0 for all the populations with the 
exception of the Nama, SAC and SAW (see Table 3.4). Grouping of data according 
to continental descent showed that the European population had the highest gene 
diversity for this locus whilst the Asian population had 0% diversity for this marker 
(see figure 3.10). 
 
For the CYP3A4 locus, the lowest diversity indices were noted in populations of 
Asian and European descent whilst the SAC had the highest diversity for this locus 
(See Table 3.4). Although the Eurasian populations had the lowest diversity for the 
CYP3A4, the opposite was noted for the V89L gene variant, where they had the 
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highest indices. The three Khoisan-speaking populations, Nama, !Kung and the 
Sekele had the lowest indices for this locus whilst the Kwengo had diversity values 
that were similar to those of the Bantu-speaking populations.     
  
 
Figure 3.10. Genetic diversity indices of the three continental groups for all loci. 
The SAC group was included in the African sample 
 
KLK3 
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Table 3.4 Distribution of gene diversity per locus for each of the 14 populations. 
   GENE-DIVERSITY ESTIMATES  
POPULATIONS N* CYP17A1 CYP3A4 V89L A49T KLK3 AR 
SEB 91 0.4366  0.4284  0.3852  0.0000  0.4989  0.8921  
SWB 90 0.4223  0.3598  0.4035  0.0000  0.4869  0.9046  
ZAM 55 0.4764  0.3545  0.4444  0.0000  0.4619  0.9172  
DRC 117 0.4435  0.3275  0.4067  0.0000  0.4928  0.9078  
UGA 120 0.4435  0.4346  0.4406  0.0000  0.5012  0.9056  
CAR 32 0.3472  0.4479  0.4241  0.0000  0.4678  0.9173  
PYG 27 0.4920  0.4249  0.2572  0.0000  0.4983  0.8575  
NAM 19 0.4908  0.4225  0.1494  0.0526  0.4623  0.9532 
!KUN 27 0.4920  0.2572  0.2830  0.0000  0.5066  0.8832 
SEK 56 0.4884  0.3958  0.1491  0.0000  0.5031  0.8344 
KWE 31 0.5077  0.3728  0.3892  0.0000  0.5077  0.8860 
SAC 56 0.4773  0.4987  0.4194  0.0526  0.4884  0.9091  
SAW 49 0.4513  0.2013  0.4696  0.0204  0.4749  0.8971  
SAI 45 0.3735  0.1258  0.4854  0.0000  0.5016  0.9192  
 815 0.4788 0.4708 0.3799 0.0107 0.4992 0.9116 
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3.3.3 INTERPOPULATION DIVERSITY 
 
FST STATISTIC 
 
 
To quantify the extent of between-population variation, among the populations, 
Wrights Fst Statistic was computed for different population groupings (see figure 
3.11). The highest Fst value (0.14) was noted when the populations were grouped 
according to continental descent, African, European and Asian. The African 
populations exhibited higher between population variation (0.021) than that 
observed between the European and Asian populations (0.01). The lowest Fst 
indices were noted in the Bantu-speaking populations (0.006). 
 
The SAC was grouped with its various parental populations. The highest between 
population variation was noted when the SAC was grouped with the Asian 
population. The lowest was noted when it was grouped with the SEB population. 
 
The genetic variants were also assessed to determine which variant exhibit the 
highest level of between-population variation. The highest indices were noted for 
the CYP3A4 gene variant, whilst the lowest was for the AR gene variant (see figure 
3.12).  
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Figure 3.11 Fst estimates for different population groupings. African (AFR), Europe 
(EUR), Asian (ASI). 
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Figure 3.12 Fst estimates for different genetic variants 
                                                   
KLK3 
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3.3.3 Analysis of gene flow 
 
 
In order to elucidate the amount of gene flow experienced by the different 14 
populations, a plot of heterozygosity vs. the distance from the centroid was drawn 
according to the Harpending-Ward model (Harpending and Ward 1982). 
 
From this analysis, all the populations were found to exhibit higher genetic diversity 
than would be expected under this model with the exception of the Sekele. The 
Sekele population was the only population that exhibited less heterozygosity than 
would be expected under this model. The SAC was found to be one of the 
populations that were found to be the furthest away from the theoretical regression 
line, thus indicating more gene flow into the SAC population (as shown in figure 
3.13). 
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Figure 3.13  The plot of heterozygosity vs. distance from the centroid for the 14 
populations. 
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3.4 POPULATION AFFINITIES 
 
The genetic affinities and relationships of the examined populations were 
inferred using a neighbour joining tree (as shown in Figure 3.14). From this 
tree, three distinct clusters were noted.  The first major separation is between 
African and non-African populations. The African populations clustered together 
on one branch whilst the non-African populations clustered on a separate 
branch. However, the SAC population was located in a branch that was 
between the African population and the non-African population.  
 
The African branch was further divided into two separate clusters clearly 
differentiating the Bantu-speaking populations from the hunter and gatherer 
populations.  The Khoisan-speaking populations, the Nama, !Kung, Sekele and 
the Kwengo formed a cluster with the Pygmies.  
 
The Bantu–speakers branch was however not exclusively Bantu speaking as the 
African-Americans were found to cluster within this branch. On the contrary, the 
European-Americans were however found to cluster with the SAW and SAI 
populations on the non-African branch.  
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Fig 3.14 A neighbour-joining tree showing the population affinities of the examined populations
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4 DISCUSSION 
  
 
Prostate cancer is notorious for the extreme racial disparities observed in its 
incidence rate. It has been noted that individuals of African descent, especially 
those of the African Diaspora, have a higher risk of developing prostate cancer 
than individuals of either European or Asian descent (Reddy et al. 2003). This 
thus implies that some form of underlying genetic structure, which is present in 
both the current African populations and the exiled populations might exist, which 
might be responsible for the ethnic differences in incidence rates. 
 
Several polymorphisms in the androgen biosynthesis and metabolism cascade 
have been identified that are hypothesised to increase the risk to prostate cancer. 
These gene variants have, however, only been comprehensively studied in the 
European, Asian and African-American populations. This bias in sampling and 
the scarcity of data on the frequency distribution of these gene variants in sub-
Saharan African prompted the initiation of the current study. This study is the first 
attempt to comprehensively explore the distribution of these variants in sub-
Saharan African populations and include hunter and gatherer populations in the 
dataset.  
 
Furthermore, this study allows for the comprehensive analysis of genetic 
variation among sub-Saharan African populations, which still remain largely 
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understudied despite the important historical implication these populations have 
with regards to human evolution. 
 
4.1 TRENDS AND PATTERNS FROM FREQUENCY DISTRIBUTIONS 
 
Analysis of the variant alleles on an individual level, led to the identification of 
certain trends and patterns from the frequency distribution of these alleles. These 
trends and patterns were found to be in accordance with the known history of 
some of these populations. Thus, emphasising the critical role that population 
genetics should play when association studies and remedial interventions 
strategies are designed.   
 
From these trends and patterns, four inferences were made. These include:  
1. Historic implication of the frequency distribution of the variant alleles 
2. Origins of the variant alleles 
3. Association of the variants with prostate cancer 
4. Interaction between genetic and environmental factors 
 
It is however important to note that only six markers were examined in the current 
study and thus the inferences that were made from the data are limited. 
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4.1.1 Frequency distribution and Intrapopulation diversity  
 
CYTOCHROME P450C17Α (CYP17A1) 
 
There was a high difference in the frequency distribution of the variant allele 
between the CAR and Pygmies reaching statistically significant P value of 
<0.0001. This in light of the close living proximities of the two populations, as well 
as the long history of contact between these two populations is quite surprising. 
Although, the Pygmies are primarily hunters and gatherers, some maintain a 
close relationship with the neighbouring farming populations. They not only 
exchange their game and labour for tobacco and alcoholic beverages, but have 
also adopted the language of these neighbouring populations (Cavalli-Sforza et 
al. 1994).  As a result of these relations, there has been a substantial amount of 
gene flow from the Pygmies into their neighbouring Bantu-speaking populations 
and vice versa.  Thus when the extent of the genetic contributions made by 
Bantu-speaking males into the Pygmy population was calculated, it was found to 
be more than 50% (Cruciani et al. 2002).  
 
The distribution patterns of the CYP17A1 variant allele, however does not 
illustrate this extensive contact and significant gene exchange between these two 
populations. It seems that the Pygmies have retained their ancestral frequencies 
of the variant allele.  This is also illustrated by frequency distribution patterns and 
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gene diversity indices that are similar to those of groups that were priorily known 
as hunter and gatherer populations (Khoisan-speaking populations). 
 
THE CYTOCHROME P450 3A4 (CYP3A4) 
 
Extreme ethnic variation in the frequency distribution of the CYP3A4 (G) allele 
was observed in the dataset. This allele was observed in high frequencies in 
African populations but was found in frequencies of less than 12% in non-African 
populations (European and Asian descent). Furthermore, the highest between-
population diversity in this data was observed for this marker. Thus, this variant in 
conjunction with other ancestry informative markers would be very useful in 
making inferences on the geographic origins of individuals. This continentally 
determined distribution was also noted in the presence of comparative data, 
further accentuating the African specificity of this marker.  
 
The SAC had intermediary frequencies between the African populations and 
European populations as well as the highest gene diversity for this 
polymorphism. These are signatures that indicate a state of admixture. The 
precise biological history of the South African Coloured population is not clear, as 
there was no single source but rather through a number of successive events. 
However, the emergence of the SAC population can be traced back to the shores 
of Table Bay a few years after the Dutch settlement. This population formed as a 
result of relations between the Dutch Settlers and the Khoisan women.  Later, 
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various genetic contributions from the Bantu-speaking, Asian and other European 
populations (Nurse et al. 1985) entered the SAC genetic pool. Thus the SAC 
population is a highly admixed population having received contributions from 
multiple parental populations. Therefore the presences of intermediary allele 
frequencies between the parental populations as well as the high gene diversity 
and gene flow are testimony to this state of admixture. 
 
STEROID 5  REDUCTASE TYPE II (SRD5A2) V89L 
 
The frequency distribution of the leucine variant increased with a pattern of 
increasing distance from Africa. As a result, populations of Asian origin 
harboured the highest frequencies for this allele. Thus, signifying that this allele is 
likely to have gained importance with the Out of Africa migration. 
 
The lowest gene diversity was observed in the hunter and gatherer populations 
with the exception of the Kwengo. The low diversity indices in these populations 
could be a consequence of the demographic histories of these populations. The 
hunter and gatherer populations maintain small population size and live in 
isolation, making the effects of genetic drift more pronounced in these 
populations (Oota et al. 2005). The Khoisan-speaking populations (the Nama and 
the !Kung), have in the recent past undergone two major successive bottleneck 
events. The wars with the settlers over Khoisan speakers‟ cattle stealing 
tendencies and the small pox epidemic greatly reduced the effective population 
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size of these populations in Southern Africa. One of the great consequences of 
major bottleneck events is the reduction in diversity of the affected populations. 
 
The Kwengo population on the other hand, was found to statistically differ to the 
other Hunter and gatherer populations. However, when it was compared to the 
Bantu-speaking populations, no significant differences were noted. The Kwengo 
have often been called the Black Bushmen, due to their striking similarities in 
physical appearance to the Bantu-speaking populations.  It was postulated that 
the Kwengo were initially Bantu speaking populations that adopted the Khoisan 
language. Studies based on mitochondrial DNA have shown that the Kwengo are 
genetically more similar to the Bantu-speaking populations than to the Khoisan-
speaking populations (Chen et al. 2000). 
 
STEROID 5  REDUCTASE TYPE II (SRD5A2) A49T 
 
Of the loci examined, the A49T locus was the least variable and had frequencies 
of zero in 11 out of the 14 populations examined. The variant allele was absent in 
all the population in our current dataset with the exception of the Nama, SAC and 
SAW where it was found with frequencies of less than 3%. Even in the presence 
of comparative data, this allele is found in minute frequencies in world 
populations. However, the European populations seem to generally have higher 
frequencies of this polymorphism as compared to other populations. 
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The fact that this allele is found in such small frequencies across the globe 
strongly indicates that this allele is a newly arisen allele. Up to date, there has 
been no report of this allele in Asian populations. 
 
KALLIKREIN RELATED PEPTIDASE 3 GENE (KLK3) 
 
The KLK3 locus exhibited the highest diversity values in all the SNP variants that 
were examined. This suggests that this polymorphism might be the oldest of the 
SNP variants that was examined, as there is a direct correlation between gene 
diversity and the age of the mutation (Jorde et al. 2001). Also there was no 
evident clustering pattern of frequency distribution amongst the examined 
population. This observation suggests that this locus is highly unlikely to have 
been under any selective pressures or gained importance during the Out of Africa 
migrations 
 
The SAI were noted to have frequencies that were significantly different to those 
of other Asian populations. This pattern was also noted in both the CYP17A1, 
V89L and AR variants. It was unfortunate that in the case of SAI, we were 
restricted in comparative analysis to populations that did not directly contribute to 
the gene pool of SAI. This could be the reason for the significant differences that 
were noted between the SAI and populations of Asian descent. 
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ANDROGEN RECEPTOR (AR) 
 
The highest gene diversity of all the examined loci was observed in the AR locus. 
This high diversity is attributable to the fact the STR markers have a high 
mutation rate and are therefore extremely fast evolving (Zhivotovsky et al. 2003). 
Thus making inferences on relatively recent population divergence possible 
(Romualdi et al. 2002).  This is evident from the ability of this marker to decipher 
variation patterns within Africa. 
 
There was a great distinction in the distribution of repeat units of less than 20 
between the Hunter and gatherer populations and the Bantu speaking 
populations. Furthermore all the Bantu-speaking populations with the exception 
of Uganda had modal repeat units that were less than 20 whilst the hunter and 
gatherer populations had modal repeat units that were either above or equal to 
20.   
 
The close genetic similarities of Bantu speaking populations have been 
previously documented. The Bantu speaking populations currently occupy more 
than one third of the African continent and had come to occupy this vast land 
through one of the most significant population expansions in Africa, the Bantu 
expansion. This expansion was due to the introduction of plants from South East 
Asia and was the resultant migration in search for more land to accommodate the 
increase in population size (Murdock et al. 1959). It took place approximately 
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5000 years ago and led to the spread of agriculture to the southern parts of the 
continent (Pereira et al. 2001), which were originally inhabited by the Khoisan 
speaking populations (Soodyall et al. 1992).  
 
The Bantu expansion took place in two routes, the south-westerly and the south-
easterly routes. The south-westerly route spread to the south along the shores of 
the Atlantic Ocean, whilst the south-easterly route passed through the rainforest 
and settled briefly in the Great lakes and later advanced to the southern tip of the 
continent. Both routes are postulated to have originated from the ancestral 
homeland that was in the border of Cameroon and Nigeria. It is however 
contemplated that intermingling between the two routes had occurred at different 
times during the expansion although the specifics are still unclear (Plaza et al. 
2004).  
 
This repeat unit, in combination with other ancestry informative markers would be 
useful in the elucidation of variation patterns within Africa especially because of 
the differences in frequency distribution between Bantu speaking and hunter and 
gatherer populations. The presence of repeat units of less than 20 appears to be 
highly prevalent in Bantu speaking population and in conjuction with other 
markers, can thus be used to trace and form conclusive results on the spread of 
Bantu speaking populations across the African continent.  
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4.1.2 ORIGINS OF THE VARIANT ALLELES 
 
The presence of four gene variants (CYP17A1, V89L, KLK3 and AR) in 
frequencies of more than 10% across the global populations suggests that these 
variants predate the human divergence period. The distribution of these four 
gene variants in the African as well as non African populations indicates that 
these polymorphisms were present in the ancestral African populations and are 
therefore present in the non African populations due to the contribution from the 
ancestral population. 
 
The A49T polymorphism was however not observed in African and Asian 
populations with the exception of one Nama and three SAC individuals. Higher 
frequencies of this polymorphism, although in small frequencies, are observed in 
populations of European descent as compared those of either African or Asian 
descent, thus suggesting that the roots of this polymorphism are highly likely to 
be traced back to Europe. However, this observation does not explain the 
presence of this variant in the two African populations. When the Y chromosome 
data of these African individuals carrying the variant allele was ascertained, all 
four were found to belong to the M207 haplogroup, a haplogroup that is found 
predominantly in the European populations and also known as a European 
specific Y chromosome marker. Due to the known history of contact between the 
SAC and Nama with European populations, the presence of this polymorphism in 
the African populations is likely to be as a result of this extensive contact.  
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Furthermore, the low frequency with which this variant is found even in the 
European populations in which it originated from indicates that it is newly arisen 
polymorphism. This variant allele must have already been present in the 
European populations prior to the year 1652 when the Dutch settler arrived in 
South Africa and were thus able to introduce it to the Khoisan speaking 
populations and in the newly formed SAC population. 
 
There is very evident frequency differences in the distribution of the CYP3A4 (G) 
allele between African and non-African populations. The G allele is found in 
frequencies ranging from 67% to 90% in African populations whilst the A allele is 
found in frequencies of 89 to 93%. This then begs the question of which of these 
two alleles is the ancestral one. Since the African populations are regarded as 
the ancestral population that gave rise to all other existing populations, there is a 
high probability that the G allele might trace its origins back to Africa and be the 
ancestral allele. But due to the ascertainment bias of this allele in European 
populations, the CYP3A4 (A) allele was thought to be the ancestral allele 
(Rebbeck et al. 1998). Furthermore, the presence of the A allele in frequencies of 
more than 10% in the ancestral African populations strongly suggests that this 
allele arose before the Out of Africa expansion. Selective pressures coupled with 
the bottleneck events and rapid expansion of the European and Asian 
populations with the Out of Africa expansion must have led to the high 
frequencies with which it is seen in these populations. However, comparing the 
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human CYP3A4 sequence to that of the Pan Tryglodes might help to form 
conclusive results on which of these allele is the ancestral one. 
 
Many might argue that we should move towards classifying DNA changes by 
state rather than calling them ancestral or derived, particularly since both these 
alleles are found in frequencies of more than 80% in the African and Eurasian 
populations. Whilst this argument is true and valid, it is critical for geneticists to 
understand which alleles are ancestral, as this allows them to fully understand 
the selective factors that drove the variant allele to such high proportions in either 
the African or Eurasian populations. This will consequently add to the growing 
body of knowledge on the drivers of human genomic variation.  
 
4.1.3 ASSOCIATION OF VARIANTS WITH PROSTATE CANCER 
 
Four gene variants out of the six that were studied in the current dataset showed 
frequency distribution patterns that greatly mimicked prostate cancer incidence. 
These include the CYP17A1, CYP3A4, V89L and AR gene variants. Populations 
of African descent, particularly African-Americans, have a extremely high 
incidence of prostate cancer whilst the Asian populations have the lowest 
reported incidence, which is 50 fold lower than the high risk African American 
populations (Keita et al. 2004; Hsing et al. 2001). 
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When analysis was restricted to the current data set, the CYP17A1 (C) allele that 
is said to increase risk to prostate cancer was found in higher frequencies in the 
high risk African population as compared to the SAI, which are considered the 
low risk group. The SAW population was however noted to exhibit intermediary 
frequencies. However, when comparative data was added, the reverse was seen. 
The Asian populations (Japanese and Taiwanese) populations had the highest 
frequencies of the variant allele, followed by the African populations. It is highly 
probable that the small sample size of SAI population (n=45) in comparison to 
the 538 Asian individuals in comparative data, is the reason for this deviation.  A 
larger sample size of the SAI might show a different picture, one that is in 
concordance with other Asian populations. 
 
The CYP3A4 showed the most distinctive pattern that greatly resembled that of 
prostate cancer incidence. Extremely high frequencies of the G allele, which is 
said to increase prostate cancer risk, were found in African populations. 
Frequencies of below 10% were found in Asian and European populations. The 
Asian populations had the lowest frequencies for this allele. 
 
The leucine allele is said to confer a protective effect against prostate cancer to 
those carrying this allele. This allele was found in high frequencies in Asian 
populations, followed by European populations. The African populations as well 
as the African- American population had the least frequency of the protective 
leucine allele.  
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The effect of short repeat units (<20) has long been researched as a potential 
risk factor for prostate cancer.  These short repeat units were found to be 
extremely common in Bantu speaking populations as well as the extremely high 
risk African-Americans. The short repeat units were however found in low 
frequencies in the both the Asian and European populations. This frequency 
distribution pattern further increases the likelihood of this polymorphisms being 
associated with prostate cancer. 
 
The distribution of KLK3 and A49T polymorphisms did not however illustrate a 
pattern that coincided with prostate cancer incidence. It is highly probable that 
the KLK3 acts in conjunction with other markers, the most likely candidate being 
the AR (CAG) repeat unit, to exert an effect. The combination of the KLK3 (G) 
allele and the short AR repeat units (<20) have been previously shown to 
increase risk to prostate cancer (Xue et al. 2000). 
 
The A49T gene variant, because of its likely origins in Europe and the low 
frequencies with which it is found in Africa, is highly unlikely to greatly increase 
risk to prostate cancer in African populations. This polymorphism might however 
be a genetic predisposing factor in European populations and populations with 
European contributions. The distribution of this variant allele highlights some of 
the challenges faced by disease studies on the risk classification of subjects in to 
groups that may not be very robust. Due to the high level of admixture in the SAC 
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and Nama populations as well as the low frequencies with which this allele is 
found in these populations, spurious associations for this allele might be noted. 
This emphasises the importance of understanding the genetic structure and 
history of populations prior to conducting such studies.  
4.1.4 INTERACTION OF GENETIC AND ENVIROMENTAL FACTORS 
  
Most complex diseases, like prostate cancer, manifest as a result of complex 
interactions between environmental and genetic predisposing factors. These two 
factors cannot act solely to bring about the disease state (Wright et al. 1999). 
Therefore in order to develop the disease state, a combination of the genetic 
predisposing makeup coupled with exposure to the environmental triggers is 
required. 
 
Due to the unique history of African-Americans, the genetic affinities of this 
population were inferred using a neighbour joining tree. From this, it was 
observed that African-Americans and African populations have similar genetic 
makeup for the predisposing gene variants. This observation is consistent with 
their known history of a sub-Saharan African origin. The African-Americans are 
descendants of African slaves that were taken from sub-Saharan Africa to work 
at sugar plantations in various American colonies. From 1518 up until 1870, 
when the practise of slavery was abolished, a total of 10 million slaves had been 
sent to the Americas. The great source of slaves during this period was the West 
and Central African states. However by the late 18th century, the source had 
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extended to regions in Southern and East Africa. Additional genetic contributions 
from European American and American Indians entered the genetic pool of the 
African-Americans with the settlement in the American colonies, thus making this 
population highly admixed (www.history.com). 
 
However, despite these genetic similarities, there is an evident difference in the 
incidence rate of prostate cancer in the continents where these two populations 
currently reside. American populations have an incidence rate that is almost 
three times as high as the incidence rate observed within African continent 
(Parkin et al. 2005). Since both these populations have the same genetic 
makeup, the only varying factor that could possibly explain the discrepancies in 
the incidence rate is the exposure to the environmental stimuli. 
 
One of the environmental factors that have long been researched for its 
contribution to prostate cancer risk is the intake of a diet high in fat content. It has 
been noted that the incidence of prostate cancer increases when individuals from 
the low risk population groups move to the high risk population regions for 
example the Japanese living in Brazil have a higher incidence of prostate cancer 
than the Japanese living in Japan (Iwasaki et al. 2004).  
 
Furthermore, in other cancers particularly breast cancer where a diet high in fat 
intake is also considered a risk factor, although inconclusive results have been 
noted in this regard (Fung et al.), the highest incidence rates are observed in 
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North America (Parkin et al. 2005). These observations accentuate the fact that a 
diet high in fat intake is very likely to represent one of several candidates that 
increase risk to prostate cancer and might be the one of the reasons for the 
differences in incidence rate between African-American and their founding 
African populations. As African populations adopt a more westernised diet, an 
increase in the prostate cancer incidence might be seen. It is however important 
to note that there are other potential environmental factors, such as lifestyle and 
smoking, that are likely to increase risk to prostate cancer. The current study 
supports the view on the requirement of both the genetic and environmental 
factors concurrently in order to bring about the disease state. It also further 
emphasises the point made by Tishkoff and Williams 2002, which stressed how 
studying genetic variation in Africa might consequently lead to the discrimination 
of environmental factors from genetic contributions in complex diseases (Tishkoff 
and Williams 2002). 
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4.2 GENETIC VARIATION AMONG AFRICAN POPULATIONS 
 
The analysis of genetic variation and structure in African and non-African 
populations using all the six polymorphisms highlights and cements genetic 
findings that have been previously and extensively documented even though only 
a limited number of markers were used. 
 
1. Evolution of modern human 
2. Prehistory of the Khoisan speaking populations 
3. The genetic structure of the SAC 
4. The Bantu Expansion 
4.2.1 Evolution of modern humans 
 
The current data supports the theory that has been previously postulated on the 
evolution of modern humans within Africa. A number of key findings from the 
current study show support for the “Out of Africa” theory and the rapid expansion  
of the Eurasian populations.  
 
Firstly, African populations had the highest overall diversity for the markers 
examined, despite the fact that most of these markers had been ascertained in 
European, Asian and American populations.  Also, a trend of decreasing diversity 
with increasing distance from Africa was noted, with Asian populations having the 
lowest diversity indices. Higher diversity among African population as compared 
to non-African populations has been previously documented for various genetic 
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systems, Y chromosome, Mitochondrial, Autosomal SNPs and STRs as well as 
for Alu polymorphisms (Watkins et al. 2001) 
 
Secondly, the highest measure of between-population variation (Fst) was noted 
when the populations were grouped according to their continental origin. The 
removal of African populations reduced this statistic from 14% to 1%, illustrating 
that African populations contribute the majority of intercontinental variation and 
that more variation occurs within African populations than between the two non-
African (European and Asian) populations.   
 
Lastly, the clustering patterns of the neighbour-joining tree are in concordance 
with those observed with Y chromosome and mtDNA data (Jobling and Tyler-
Smith 1995, Jorde et al. 1998 and Zhitovosky et al. 2003). The first distinct 
separation is between the African and non-African populations, signifying one of 
the prominent characteristics of the Out of Africa migration.  
 
All the above-mentioned observations are aligned with the origin of modern 
humans from Africa. The high genetic diversity observed in Africa might be 
indicative of the fact that the African populations had more time to diversify as 
they were the founding populations. Furthermore, the reduction of diversity in 
non-African populations could be the consequence of the exodus of a limited 
subset of variation from Africa, which was further reduced by the series of 
bottleneck events followed by rapid expansion.   
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4.2.2 Prehistory of Khoisan-speaking populations 
 
The term Khoisan was invented by Schulze to collectively group the Khoi-Khoi 
populations with the San populations. However, there has been ongoing debate 
on the collective grouping of the Khoisan-speaking populations due the cultural 
and linguistic differences observed between these populations, which might be 
indicative of separate origins for these populations (Soodyall et al. 1992).  
 
When the genetic affinities of the Khoisan speaking population were assessed 
using a neighbour joining tree, all the Khoisan speaking populations were found 
to form a cluster within the African branch. There were no distinctions in the 
clustering of the the Khoi-Khoi (Nama) and the San populations (!Kung, Sekele 
and Kwengo) that would suggest separate origins of these two populations.  
Infact the Khoi-Khoi population was found to cluster in a branch with two of the 
San population (Kwengo and !Kung) further showing lack of support for the 
separate origins of these populations.  
 
Moreover, when the between-population variation of the San populations was 
assessed, an Fst value of 1.3% was noted. This value was reduced to 1.1% 
when the Khoi-Khoi population was included in the analysis. This further 
emphasises the lack of population differentiation between the Khoi-Khoi and the 
San populations.  
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Even though the separate origins of the Khoi-Khoi (Nama) and San (Sekele, 
Kwengo and! kung) populations have been previously postulated, the current 
data does not support this view and suggest that these two populations are 
mostly likely to share a common origin and ancestry.  Despite the fact that the 
Kwengo have been previously suggested to have a Bantu-speaking origin and 
mitochondrial DNA studies have shown the Sekele to be genetically similar to the 
Bantu speaking populations (Soodyall et al. 1992), these observations were not 
noted in the current dataset when all the markers were assessed collectively. 
These populations do not exhibit large genetic differences that would render 
them as populations of separate origins. 
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4.2.3 The genetic structure of the SAC 
 
 
Consistent with the observation noted for the CYP3A4 genetic variants, the 
analysis of the genetic structure of the SAC, yielded results that were in 
accordance with the known history of the South African Coloured.  
 
Of the populations examined, the SAC had the highest overall genetic diversity. 
Furthermore when the analysis of gene flow was performed, the SAC were found 
to be the furthest away from the theoretical regression line, indicating more gene 
flow has occurred into this population. These observations are consistent with the 
contribution of multiple parental populations into the SAC genetic pool. 
 
However, when the SAC was grouped with the different parental populations, the 
lowest Fst value was observed when it was grouped with the Bantu-speaking 
populations whilst the highest value was noted when grouped with the Eurasian 
populations. This observation suggests that the sample of SAC that were used in 
the current study is genetically more similar to the Bantu-speaking populations as 
opposed to the other SAC parental populations. 
 
The genetic structure of the SAC poses a variety of challenges for disease 
studies using these gene variants in the SAC population. Prostate cancer 
association studies have been plagued with inconsistencies on the link between 
these gene variants and prostate cancer susceptibility, particularly in the African-
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American populations. Population structure has often been cited as the reason 
behind the lack of replicability observed in association studies. Many maintain 
that populations that are extremely heterogeneous and exhibit large genetic 
diversities are highly likely to be affected by population stratification (Kittles et al. 
2002). Due to the highly admixed nature of the SAC, spurious associations in 
disease studies might be noted, particularly due to the large variation in the 
frequency distribution of these gene variants in the parental populations of the 
SAC. Thus the underlying genetic structure of such a population is an important 
consideration to be taken into account when designing association studies using 
these gene variants. 
 
4.2.4 The genetic structure of the Bantu-speaking populations 
 
The patterns of genetic variation that were observed in the AR repeat unit for the 
Bantu-speaking populations were also noted when analysis was done for all the 
gene variants. The results of the overall analysis further highlighted the relatively 
recent divergence of the Bantu speaking population from the same ancestral 
population on the border of Cameroon and Nigeria. The recent divergence of 
these populations was not only emphasised by their clustering pattern on the 
neighbour joining tree but also by their levels of between-population variation.  
 
When the population affinities of the Bantu-speaking populations were assessed 
using the neighbour joining tree, these populations were found to cluster on the 
African branch, which was then further divided into the Bantu-speaking and the 
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Hunter and gatherer branches. Also, the clustering pattern in the Bantu-speaking 
branch did not coincide with the two different paths (south-easterly and south-
westerly) that were taken by these populations from their ancestral homeland to 
the southern tip of the African continent. Furthermore, the lowest between-
population variance (Fst) for the different groupings was observed among the 
Bantu-speaking populations. 
 
These observations provide further testimony to the rapid expansion and the 
relatively recent dispersion of these populations within the southern parts of the 
African continent and support the linguistic evidence on this expansion (Murdock 
et al. 1959 and Plaza et al. 2004). 
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5 CONCLUSION 
 
This study is the first to comprehensively examine the frequency distribution of 
the gene variants in the androgen biosynthesis and metabolism cascade in sub-
Saharan Africa and include the hunter and gatherer populations in the sample.  
The frequency distribution patterns of these genetic variants in the current study 
are in accordance with the other published data and highlighted key facts. 
 
 The distribution patterns of these genetic variants are aligned to the 
demographic histories of these populations. Thus signalling the importance 
of fully understanding the history of these genetic variants as well as that of 
the populations where they will be examined. 
 Also, the distribution patterns of the genetic variants amongst the 
populations showed great alignment to prostate cancer susceptibility. 
Thereby providing support to the likelihood that these variants increase risk 
to prostate cancer susceptibility. 
 Furthermore, the current study highlights the importance of the link between 
both the genetic and environmental factors to disease susceptibility, 
particularly prostate cancer.  The African-American population, although 
they share great genetic similarity for these variants to their founding African 
populations, have a greater incidence for prostate cancer.    
 This study also provides further testimony to the “Out of Africa” theory and 
other important historical events in Africa. 
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5.1 FUTURE STUDIES 
 
Future studies should focus on the link between these gene variants and prostate 
cancer risk. In order to get more comprehensive results, these markers should 
not be examined in isolation, as they are most likely to be low penetrance genes 
and exert small effects on their own, an effect that might go unnoticeable in 
association studies.  It is however imperative that knowledge of genetic structure 
be discerned before performing large-scale association studies especially in 
admixed populations.  The following are great considerations for future studies. 
 
5.1.1 POPULATION GENETICS 
 
The knowledge of population history is essential when designing association 
studies. The frequency distribution of alleles and genomic diversity observed 
within and between populations is heavily influence by the history of a particular 
populations. Since association studies are based on the premise that differences 
in allele frequencies between groups (cases and control) is due to association 
with the disease, knowledge and analysis of factors that can potentially skew the 
results is of paramount importance. Knowledge of population history is one of the 
elements that are critical in the design of these studies. The genetic structure in 
the SAC and African-American populations needs to be comprehensively 
examined when designing association studies using these gene variants; 
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especially since these gene variants are distributed differently in the parental 
populations that gave rise to these two populations. 
 
5.1.2 STUDIES IN AFRICA 
 
As previously stated by Tishkoff and Williams 2002, this study illustrates that 
studying African populations will allow for the discrimination of environmental 
contributions from genetic ones. This was highlighted by the fact that even 
though African-American populations have similar genetic makeup for the gene 
susceptibility variants to the sub-Saharan African population, differences in 
incidence rate are still evident. This highlights the role of environmental factors in 
increasing risk to prostate cancer such as a high fat diet, lifestyle and smoking. 
 
Furthermore, this study has added to the growing body of knowledge on genetic 
variation in African populations and the evolution of modern humans. Analysis of 
genetic variation in the current study, showed the same patterns of African 
genetic variation that have been noted in other studies and further supported the 
“Out of Africa” theory. More studies on the analysis of genetic variation in African 
population need to be performed as this could help form a clearer picture on the 
evolution of modern humans.  
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5.1.3 Epidemiological studies 
 
Another worthwhile experiment would be the elucidation of the relationship 
between a diet high in fat intake and prostate cancer incidence. Large-scale 
epidemiological studies would need to be performed to determine if there is a 
correlation between fat intake and the presence of genetic predisposing gene 
variants to developing prostate cancer.  
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6 APPENDICES 
 
6.1 RECIPES AND SOLUTIONS 
 
 
TE Buffer 
 
Dissolve 1ml of Tris HCl(IM) in 200 l of EDTA (ph 8.0) . Add 100ml of dH2O. The 
ph of the solution should be 8.0 
 
10X TBE 
 
Dissolve 108 g of Tris base and 55 g boric acid in 800 ml of dH2O. Add 40 ml of 
0.5 M EDTA (pH 8.0) and make up to 1 litre. The pH of this stock should be 
approximately 8.3 
 
1X TBE 
 
Mix 100 ml of 10X TBE stock and 900 ml of dH2O to make 1 litre of 1X TBE 
solution 
 
 
3% AGAROSE GEL 
 
Add 3g of agarose to 100ml of 1X TBE, and heat to dissolve. Allow to cool 
slightly and then add 3µl of ethidium bromide before setting 
 
 
3% NUSIEVE GEL 
 
Add 3g of Nusieve to 100ml of 1X TBE, and heat to dissolve. Allow to cool 
slightly and then add 3µl of ethidium bromide before setting. 
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2% NUSIEVE GEL 
 
Add 2g of Nusieve to 100ml of 1X TBE, and heat to dissolve. Allow to cool 
slightly and then add 3µl of ethidium bromide before setting. 
 
4.3% POLYACRYLAMIDE GEL 
 
Dissolve 36g urea in 10.6ml of deionised 40% bis-acrylamide, 10 ml of 10X TBE 
and approximately 50 ml of ddH2O. Stir over heat till all contents are dissolved; 
then bring volume to 100ml. Filter through Nalgene filtration system under 
vacuum pressure. Store covered in foil at 4 C. 
Sequencing gel preparation: Mix 50ml of 4.3% polyacrylamide gel with 30 l 
TEMED (as a catalyst) and 250 l 10% APS (to facilitate cross-binding) 
immediately before pouring. 
 
BROMOPHENOL BLUE FICOLL DYE 
 
Dissolve 50g sucrose, 1.86g EDTA, 0.1g bromophenol blue and 10g Ficoll in 
50ml dH O, stir overnight, pH to 8.0 and filter through Whatmann filter paper. 
 
DEXTRAN/ FORMAMIDE DYE 
 
Dissolve 20 mg Dextran (Sigma) in 1 ml Formamide 
 
2.5mM DNTPs 
 
Use 100mM premade stocks (GibcoBRL) of dATP, dGTP, dCTP and dTTP. Add 
10 l of each stock dNTP to 360 l sterile ddH2O to make 400 l of 2.5mM dNTPs. 
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6.2 INTERPOPULATION COMPARISONS USING THE FISHERS EXACT TEST 
 
Table A1: CYP17A1 pair-wise population comparisons 
 
 
SWB 
 
ZAMBIA 
 
DRC 
 
UGANDA 
 
CAR 
 
PYGMIES 
 
KHOISAN 
 
SAW 
 
SAI 
 
SAC 
 
SEB 
 
0.7337 0.3090 0.8336 0.8345 0.1519 0.0004 0.0001 0.7898 0.2579 0.2582 
SWB 
 
 0.1592 0.5942 0.5963 0.2568 0.0002 < 0.0001 0.5885 0.3901 0.1602 
ZAMBIA 
 
  0.3950 0.3362 0.0294 0.0126 0.0410 0.5635 0.0476 1.0000 
DRC 
 
   1.0000 0.0946 0.0005 0.0001 0.8989 0.1779 0.3355 
UGANDA 
 
    0.0951 0.0005 0.0001 0.8992 0.1430 0.3372 
CAR 
 
     < 0.0001 < 0.0001 0.1148 0.8471 0.0295 
PYGMIES 
 
      0.2346 0.0034 < 0.0001 0.0130 
KHOISAN 
 
       0.0063 < 0.0001 0.0425 
SAW 
 
        0.1997 0.5650, 
SAI 
 
         0.0484 
SAC 
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Table A2: CYP3A4 pair-wise population comparisons 
 
 
SWB 
 
ZAMBIA 
 
DRC 
 
UGANDA 
 
CAR 
 
PYGMIES 
 
KHOISAN 
 
SAW 
 
SAI 
 
SAC 
 
SEB 
 
0.1246 0.1772 0.0222 0.9156 0.7564 1.0000 0.1287 < 0.0001 < 0.0001 < 0.0001 
SWB 
 
 1.0000 0.5482 0.0631 0.1390 0.3712 0.9099 < 0.0001 < 0.0001 < 0.0001 
ZAMBIA 
 
  0.6724 0.0989 0.1575 0.3441 0.8940 < 0.0001 < 0.0001 < 0.0001 
DRC 
 
   0.0048 0.0453 0.1503 0.3900 < 0.0001 < 0.0001 < 0.0001 
UGANDA 
 
    1.0000 0.8715 0.0593 < 0.0001 < 0.0001 < 0.0001 
CAR 
 
     0.8424 0.1550 < 0.0001 < 0.0001 0.0005 
PYGMIES 
 
      0.3924 < 0.0001 < 0.0001 0.0002 
KHOISAN 
 
       < 0.0001 < 0.0001 < 0.0001 
SAW 
 
        0.3173 < 0.0001 
SAI 
 
         < 0.0001 
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Table A3: SRD5A2 (V89L) population pair-wise comparisons 
 
 
SWB 
 
ZAM 
 
DRC 
 
UGA 
 
CAR 
 
PYG 
 
KHOI 
 
SAW 
 
SAI 
 
SAC 
 
SEB 
 
0.7223 0.2290 0.6569 0.1617 0.6230 0.1020 0.0020 0.0741 0.0247 0.5029 
SWB 
 
 0.4268 1.0000 0.3354 0.7499 0.0713 0.0004 0.1362 0.0523 0.7903 
ZAMBIA 
 
  0.4477 1.0000 0.7369 0.0154 < 0.0001 0.5623 0.3032 0.6642 
DRC 
 
   0.5392 0.8763 0.0381 < 0.0001 0.2270 0.1003 1.0000 
UGANDA 
 
    0.7609 0.0046 < 0.0001 0.6567 0.3782 0.6467 
CAR 
 
     0.0171 0.0048 0.3688 0.1819 1.0000 
PYGMIES 
 
      0.8317 0.0006 0.0001 0.0258 
KHOISAN 
 
       < 0.0001 < 0.0001 0.0007 
SAW 
 
        0.7714 0.2925, 
SAI 
 
         0.1366 
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Table A4: SRD5A2 (A49T) pair-wise population comparisons 
 
 
SWB 
 
ZAMBIA 
 
DRC 
 
UGANDA 
 
CAR 
 
PYGMIES 
 
KHOISAN 
 
SAW 
 
SAI 
 
SAC 
 
SEB 
 
      1.0000 0.3500  0.0198 
SWB 
 
      1.0000 0.3525  0.0209 
ZAMBIA 
 
      1.0000 0.4712  0.1217 
DRC 
 
      1.0000 0.2952  0.0106 
UGANDA 
 
      1.0000 0.2899  0.0099 
CAR 
 
      1.0000 1.0000  0.2980 
PYGMIES 
 
      1.0000 1.0000  0.3050 
KHOISAN 
 
       0.4665 1.0000 0.0285 
SAW 
 
        1.0000 1.0000 
SAI 
 
         0.1302 
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Table A5: KLK3 pair-wise population comparisons 
 
 
SWB 
 
ZAM 
 
DRC 
 
UGA 
 
CAR 
 
PYGMIES 
 
KHOISAN 
 
SAW 
 
SAI 
 
SAC 
 
SEB 
 
0.0119 0.1113 0.6206 0.2020 0.1900 0.7564 0.0681 0.2545 0.1977 0.4697 
SWB 
 
 0.0002 0.0021 0.1976 0.0021 0.0425 0.3822 0.0010 0.5155 0.0038 
ZAMBIA 
 
  0.1962 0.0040 1.0000 0.3958 0.0010 0.7739 0.0098 0.4101 
DRC 
 
   0.0541 0.3197 1.0000 0.0122 0.3941 0.0816 0.7288 
UGANDA 
 
    0.0245 0.2301 0.5935 0.0224 0.7123 0.0668 
CAR 
 
     0.5701 0.0083 1.0000 0.0328 0.5251 
PYGMIES 
 
      0.1349 0.6050 0.2281 0.8679 
KHOISAN 
 
       0.0064 1.0000 0.0183 
SAW 
 
        0.0279 0.6723 
SAI 
 
         0.0661 
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